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Chapter 1: Introduction 
PFOS and PFOA as Representative PFAAs 
Perfluoroalkyl acids (PFAAs) are synthetic organic compounds which consist in 
part of a hydrocarbon-like carbon backbone in which all carbon-hydrogen bonds have 
been replaced with carbon-fluorine bonds.  Each molecule also contains an acidic 
moiety, typically a carboxylate, sulfonate, or phosphonate group (Lau et al., 2007, 2009).  
Measured pKa values for PFAAs are extremely low (≤ 1.0; Moroi et al., 2001; Goss et 
al., 2008; Cheng et al., 2009).  As such, they are almost entirely ionized at typical 
environmental pH values.  The fluorinated carbon backbone gives these compounds 
some hydrophobic character, while the charged group confers a degree of water 
solubility, lipophobicity, and surfactant activity (Lau et al., 2007; Lau, 2009; DeWitt, 
2015).  Carbon-fluorine bonds are extremely resistant to cleavage (Key et al., 1997) 
even more so than the carbon-chlorine bonds found in other stable chemicals such as 
the polychlorinated biphenyls (PCBs).  While biologically-mediated dehalogenation 
reactions involving carbon-fluorine compounds are possible, this typically requires the 
presence of at least one hydrogen bonded to a carbon, and is unable to proceed against 
a fully fluorinated carbon backbone (Key et al., 1998). 
PFAAs and chemical precursors have been used extensively as a surface 
treatment for carpets, fabric, leather, paper, and direct-contact food packaging, largely 
because of their grease, dirt, and stain-resistant properties (3M, 1999; Lau et al., 2007; 
Buck et al., 2011).  They also have been used in foams designed to fight fires involving 
flammable liquids.  This application takes advantage of the surfactant properties of these 
compounds as well as their extreme resistance to heat-mediated breakdown (Buck et 
al., 2011).  In addition, PFAAs and precursors have been used as surfactants for mining 
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and well production, as mist-suppressants in electroplating applications, and in cleaners, 
floor polishes, shampoos, and insecticide formulations (Renner, 2001; Seacat, 2002). 
 The studies described in this dissertation focus on two well-known PFAAs, 
perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).  PFOS consists of 
a fluorinated eight-carbon chain bonded to a terminal sulfonate group, while PFOA 
contains a fluorinated seven-carbon chain bonded to a carboxylate group.  These 
compounds are noteworthy for several reasons.   Both compounds possess a high 
degree of surfactant activity (Lau et al., 2007; Kissa et al., 2001).   Both have been 
produced in large quantities.  For example, estimated global production of POSF, a 
PFOS precursor, reached 4.5 thousand tons prior to 2002 (Paul et al., 2009).  Both 
compounds have been detected in tissues of humans and wildlife as well as in 
environmental matrices (e.g. soils, sediments, ground and surface water). Importantly, 
both of these eight-carbon PFAAs appear to be close to an apparent threshold (relative 
to shorter chain-length PFAAs) for significant accumulation in wildlife (Lau et al., 2007).  
Though they both would be expected to possess similar kinetic characteristics, based on 
the similar number of perfluorinated carbon atoms in each, large differences have been 
noted in their tendency to accumulate. 
 PFOS and some precursors (compounds which environmentally degrade to 
PFOS) were produced by the 3M Corporation (Seacat et al., 2002) using an 
electrofluorination process which results in a mixture of approximately 70% linear and 
30% branched products (Lau et al., 2007; De Silva et al., 2010).  Prior to 2002, 3M was 
also the largest domestic producer of PFOA, resulting in a mix of linear and branched 
products.  After 2002, DuPont became the largest domestic producer of PFOA, using a 
telomerization process that resulted in a straight-chain product.  
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As of this writing, domestic production of PFOS and PFOA has been largely 
phased out.  This began with a voluntary phase-out of PFOS and related products by the 
3M Corporation in 2002 (Lau et al., 2007).  In 2006, US EPA instituted the PFOA 
Stewardship Program.  Under this program, eight major manufacturers of PFOA agreed 
to reduce emissions of PFOA, PFOA precursors, and longer-chain carboxylate PFAAs 
by 2010, and eliminate all such emissions by 2015.  As of this writing, all eight 
manufacturers of PFOA had met the goals of the program (US EPA, 2017; DuPont, 
2017).  This progress may be contrasted with a 2006 EPA estimate of twenty million 
pounds of global PFOA production, of which more than half was produced in the United 
States (US EPA, 2009).  While the domestic chemical industry has phased out 
production of PFOS, PFOA, and longer chain PFAAs, it is not known how much the 
production of these compounds has increased elsewhere in the world as compensation.  
Moreover, shorter-chain PFAAs continue to be produced in high volumes (Buck et al., 
2011).  More recent regulatory action was taken in May 2016, when US EPA established 
health advisories for PFOA and PFOS in drinking water, setting the advisory level at 70 
parts per trillion (EPA, 2016).  
In 2001, Giesy and Kannan published their findings on the global distribution of 
PFOS in wildlife, which raised concerns about the possible importance of PFAAs as 
persistent environmental pollutants (Giesy and Kannan, 2001).  Since then, PFAAs have 
been measured in a wide range of species as well as environmental matrices far from 
any known sources (Prevedouros et al., 2006).  In virtually all cases, PFOS has been 
found at the highest concentrations (Giesy and Kannan, 2001; Kannan, 2001, 2005; 
Houde et al., 2006), although PFOA is often present at detectable levels.  Houde et al. 
(2008) measured PFOS and other PFAAs in several invertebrates, though typically at 
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low concentrations.  Other investigators have measured PFAAs in birds, reptiles, and 
amphibians (Giesy and Kannan, 2001; Kannan et al., 2001; Kannan et al., 2005).  Zhang 
et al. (2010) studied PFAAs in chickens and eggs as a potential source for human 
exposure.  
As with several other persistent organic pollutants, PFAAs have been widely 
studied in mammals that feed at the top of aquatic food webs, including seals (Ishibashi 
et al., 2008), whales (Reiner et al., 2011), and polar bears (Giesy and Kannan, 2001).  
These studies have provided evidence for very high levels of environmental exposure, 
as indicated by measured PFOS concentrations in blood exceeding 100 ppm (Giesy and 
Kannan, 2001; Moody et al., 2001).  PFAAs also have been measured in terrestrial 
mammals such as caribou (Ostertag et al., 2009) and wolves (Muller et al., 2011) to 
better understand dietary sources of PFAA exposure.  Of most significance to the 
studies which make up this dissertation, there are numerous reports of PFAAs in fish.  
PFOS and PFOA have been measured in fish collected across North America (Giesy 
and Kannan, 2001; Martin et al., 2004; Kannan et al., 2005) and in Asia (Murakami et al., 
2011). 
Toxicity of PFAAs to Mammals and Fish 
PFAAs and other Perfluoroalkyl Substances (PFASs) do not appear to form DNA 
adducts or react with proteins in ways that would cause direct cellular toxicity.  Initially, 
therefore, these compounds were considered biologically inert.  It has been widely 
noted, however, that PFAAs are structurally and (to a limited extent) chemically similar to 
fatty acids.  While they are not thought to enter into fatty-acid reaction pathways, they 
may exhibit some behaviors similar to those of ionized fatty acids, including binding to 
albumin and fatty-acid binding proteins in plasma and liver (Han et al., 2003; Lau et al., 
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2007; Dewitt, 2015).  PFAAs have been shown to interact with cell membranes (Han et 
al., 2009) and specific membrane transporters (Nakagawa et al., 2009; Zhao et al., 
2017), potentially interfering with normal membrane transport processes.  They are also 
likely to interact with nuclear receptors involved in cellular metabolism which would 
otherwise be responsive to structurally similar fatty acids (Bjork et al., 2009, 2011; 
Bijland et al., 2011; Elcombe et al., 2012).  
 A number of health effects caused by PFAAs have been noted in the literature, 
typically associated with repeat-dose, sub-chronic, or chronic exposures.  Experiments 
performed using rodents and non-human primates have demonstrated that PFAAs can 
cause weight-loss, hepatomegaly (typically hypertrophy rather than hyperplasia) with 
vacuolization, reduced serum cholesterol, and mortality (Lau et al., 2007; Seacat et al., 
2002).  Rats exposed to a high dose of PFOS developed hepatocellular adenomas 
(Seacat et al., 2003), while mice dosed with PFOA exhibited a decrease in adaptive 
immune response (Yang et al., 2002, DeWitt et al., 2008).  In a number of studies in 
which mice were dosed with PFOA during gestation, mammary tissue development was 
impaired in both dams and offspring (Macon et al., 2011; White et al., 2007, 2008, 2011).   
Several PFAAs have been shown to exhibit endocrine activity (Kjeldsen and 
Bonefeld-Jorgensen, 2013).  For example, pregnant rats dosed with perfluorodecanoic 
acid (PFDA; Langley et al., 1985) or PFOS (Thibodeaux et al., 2003) exhibited 
decreased levels of serum T3 and T4.  Fluorotelomer alcohols, precursors which may 
degrade to PFAAs, were shown to induce MCF-7 human breast cancer cells, thereby 
providing evidence for an estrogenic effect (Maras et al., 2006). 
The potential for PFAA toxicity mediated by peroxisome proliferator-activated 
receptor alpha (PPARα) has been extensively investigated (Rosen et al., 2008; Bjork 
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and Wallace 2009, Bjork et al., 2011).  Studies of liver tumors in rodents demonstrated 
compatibility with PPARα receptor-mediated toxic effects (Klaunig et al., 2003).  
However, this toxicity pathway is not considered to be relevant to human disease (Lau et 
al., 2007; Corton et al., 2014).  Other studies have found that hepatotoxic effects in liver 
were due, in part, to activation of CAR/PXR as well as PPARα (Bijland et al., 2011; 
Elcombe et al., 2012).  PFAAs were also shown to interact with the peroxisome 
proliferator-activated receptor gamma (PPARγ) in mouse and human cells (Takacs and 
Abbott, 2007).   
Toxicity studies with PFAAs in fish have largely focused on the effects of PFOS.  
These investigations have demonstrated reproductive impairment in adult swordtails 
(Xiphoophorous hellerii) and developmental toxicity in swordtail embryos (Han and Fang, 
2010).  Other work provided evidence for hepatotoxicity in common carp (Cyprinus 
carpio; Hoff et al., 2003) and effects on zebrafish (Danio rerio) embryo behavior (Huang 
et al., 2010).  Shi et al. (2008) found that PFOS exposure during early development 
produced developmental effects on zebrafish larvae, including spine curvature and heart 
malformations.  Another study using zebrafish found that organogenesis was impaired in 
zebrafish larva exposed to PFOS during early development (Chen et al., 2014).  These 
effects were correlated with numerous changes in gene expression, including changes in 
expression of several genes known to be involved in organ development.  Wei et al. 
(2008) used cDNA microarray analysis to study effects on gene transcription in rare 
minnows (Gobiocypris rarus) exposed to PFOA.  The observed effects were similar to 
those associated with PPARα activation in mammals.  In addition, the authors noted a 
downregulation of genes involved in biosynthesis of thyroid hormone, and liver 
histopathology similar to that seen in mammals.  A number of PFAAs and precursor 
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compounds were shown to induce vitellogenin production in Nile tilapia (Oreochromis 
nilotichus) hepatocytes (PFOS 48 h EC50: 1.5*10-5M; PFOA: 2.9*10-5M) which is a 
marker of estrogenic activity (Liu et al., 2007). 
PFAA Kinetics in Mammals 
A standard approach for describing chemical kinetics in biological systems is to 
independently consider the processes of absorption, distribution, metabolism, and 
elimination (ADME).  Each of these processes impacts the rate and extent of chemical 
accumulation.  They also determine, for a given exposure scenario, the chemical 
concentration-time course in target tissues, which may be associated in turn with 
observed toxic effects.   
 Dietary uptake of PFAAs has been studied extensively.  PFOA was shown to be 
more than 90% absorbed in feeding studies with rats (Johnson et al., 1979).  Similar 
high dietary absorption efficiencies were observed in feeding studies with rabbits, mice, 
and hamsters (Hundley et al., 2006; Jandacek et al., 2010).  Carboxylate PFAAs other 
than PFOA are also taken up from the diet with high efficiency (Kudo et al., 2001, 
Gannon et al., 2011).  PFOS was at least 95% absorbed in rats following oral exposure 
(Chang et al., 2012). 
 Most of the information concerning dermal absorption of PFAAs has come from 
studies of PFOA.  Using diffusion cells, Fasano et al. (2005) found that 1.4% of PFOA 
penetrated rat skin samples after a 48-hour exposure.  During the same time period, 
only 0.05% of PFOA penetrated samples of human skin.  In a second in vitro study, 39% 
and 23.4% of PFOA contained in acetone (0.5 mg in 50 µL) penetrated mouse and 
human skin samples respectively during a 24-hour exposure (Franco et al., 2012).  Kudo 
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(2015) speculated that differences between these studies may have been due to 
acetone facilitating PFOA uptake in the more recent study.  Franco et al. (2012) also 
studied absorption of PFOA in mice in vivo, and found a serum concentration of 150-226 
ppm after a 4-day exposure to PFOA applied to the dorsal side of the ear.  Earlier in vivo 
studies conducted using rabbits provided evidence for dose-dependent dermal 
absorption of PFOA (Kennedy, 1985). 
 Radiolabeled PFOA administered to rats by i.p. injection was shown to 
accumulate in blood, liver, and kidney; however, distribution to the liver and kidney was 
sex-dependent, with female rats showing relatively greater distribution to the kidney 
(Vanden Huevel et al., 1991; Kudo et al., 2007).  These and other studies have shown 
that the distribution of PFOA is driven by strong interactions with proteins, and that 
PFOA in plasma is bound almost entirely by serum albumin (Han et al., 2003).  
Measured PFOA liver/plasma concentration ratios were shown to increase in rats at 
lower doses (Kudo et al., 2007), possibly due to saturation of membrane transporters in 
the liver (Han et al., 2008).  Similar tissue distribution patterns have been observed for 
PFOS and other sulfonate PFAAs, with a notable exception being that PFOS 
liver/plasma ratios in rats tend to be higher (approximately 10:1) than those determined 
for PFOA (Chang et al., 2012).  Because of concerns for human developmental toxicity, 
PFOS distribution to breast milk and fetal tissue has also been studied (Hinderliter et al., 
2005).  The steady-state breast milk/plasma concentration ratio was approximately 0.1.  
A slightly higher ratio was reported for fetal tissue. 
 Studies have shown PFAAs are not metabolized in mammals.  An early study by 
Ophaug and Singer (1980) showed that PFOA administration by oral intubation had no 
effect on ionic fluoride concentration in serum or urine of female rats, demonstrating that 
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no dehalogenation reactions were occurring.  In another earlier study, male and female 
rats were given an i.p. dose of [14C] PFOA (Vanden Huevel et al., 1991).  Radiolabeled 
carbon in urine and bile was present in a single peak chromatographically identifiable 
with parent PFOA.  Other studies have failed to find phase I or phase II metabolic 
products for PFOA (Johnson et al., 1984; Ylinen et al., 1989; Kemper et al., 2005).  It is 
noteworthy, however, that while PFAAs do not appear to be metabolized in mammals, 
one of the sources of PFAAs in the environment is the degradation of precursor 
compounds (Young et al., 2010).  PFOS and PFOA may be formed by the breakdown of 
a number of precursors through both abiotic and biotic processes (Dinglasan et al., 
2004; Lau et al. 2007). 
 One of the interesting features of the PFAAs is that way that their toxicological 
effects vary, sometimes greatly, between species and between the sexes within a 
species.  In an early study with rats, Kawashima et al. (1989) showed that there were 
sex-linked differences in acute toxicity of PFOA associated with disturbances in lipid 
metabolism.  This difference was later found to be correlated with sex-linked differences 
in biological half-life (T½; Ylinen et al., 1990; Vanden Huevel et al., 1992; Kudo et al., 
2000).  Subsequent studies have shown that species and sex differences in elimination 
of PFOA can be quite large.  For example, the T½ of PFOA is a matter of hours in female 
rats (Ohmori et al., 2003) and both male and female rabbits (Kudo, 2003).  Half-lives on 
the order of days have been noted for male rats (Ohmori et al., 2003) and mice of both 
sexes (Lou et al., 2009).  In monkeys, the T½ of PFOA ranges from days to months 
(Harada et al., 2005), while in humans the T½ is several years (Olsen et al., 2007).  
Similar patterns have been observed for PFOS (Kudo, 2015) and some other PFAAs, 
though sex differences are not observed in all species.  Within a species, the T½ of a 
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PFAA tends to increase as the number of perfluorinated carbons increases (e.g., PFDA 
> PFOA > perfluorobutanoic acid; PFBA), and is generally greater for sulfonate 
compounds than for carboxylates of similar carbon chain length (e.g., PFOS > PFOA; 
Ohmori et al., 2003). 
 Because PFAAs are not metabolized, differences in T½ among species and 
sexes are largely driven by differences in elimination of the parent compound.  For non-
volatile substances, the principal routes of elimination are biliary/fecal and urinary.  In 
rats dosed with several carboxylate PFAAs, less than 5% of total elimination was due to 
elimination in feces (Kudo et al., 2005).  Administration of cholestyramine substantially 
increased fecal elimination of PFOA and PFOS in rats, suggesting that both compounds 
undergo enterohepatic circulation (Johnson et al., 1984).  Nevertheless, the feces may 
still represent an important route of elimination in cases where renal clearance is 
especially slow (e.g. PFOS and PFOA in humans, see below). 
 For most species of mammals, PFAAs are eliminated primarily in urine; however, 
measured renal clearance rates (CLR; ml/kg/day) vary widely.  For example, the CLR for 
PFOA may exceed 600 ml/kg/day in rabbits (Kudo et al., 2003) and female rats (Kemper 
and Nabb, 2003), while in male rats it tends to be substantially lower (10-15 ml/kg/day; 
Kemper and Nabb, 2003).  Renal clearance rates in humans are so low that they are 
difficult for measure.  In a study conducted by Zhang et al. (2013), the reported CLR for 
PFOA in humans was 0.03 ml/kg/day.  Renal clearance has been shown to vary with 
both carbon chain length and the identity of the acidic moiety (Lau et al., 2007).  With a 
few idiosyncratic exceptions, PFAA elimination in urine is more rapid for shorter length 
PFAAs and PFAAs containing a carboxylate group.  Slower elimination rates are 
reported for longer chain compounds and sulfonates (Ohmori et al., 2003).  Sex 
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differences in renal clearance of PFOA in rats completely resolved in castrated male rats 
treated with 17β-estradiol (Ylinen et al., 1989).  This finding demonstrated that gender 
differences in renal clearance in adult animals are under the control of sex hormones, 
and are not due to early developmental differences. 
 Renal clearance rates are determined by the processes of glomerular filtration, 
passive reabsorption, and membrane transport, operating simultaneously.  Glomerular 
filtration occurs in a capsule-enclosed capillary structure sandwiched between afferent 
and efferent arterioles (the glomerulus), and results in formation of a glomerular filtrate 
which is delivered to the renal proximal tubule.  The efferent arterioles are smaller in 
diameter than the afferent arterioles, and are able to constrict or relax in order to 
maintain hydrostatic pressure across the glomerulus.  The molecular weight cutoff for 
glomerular filtration is about 60,000 (Lote, 2001), which excludes most plasma proteins 
along with the blood cells.  As noted above, PFAAs in plasma are highly bound to serum 
albumin, leaving only a small fraction available for glomerular filtration.  For highly bound 
chemicals, the glomerular filtration rate (GFR; ml/kg/day) may be orders of magnitude 
less than renal blood flow rate. 
 Passive reabsorption occurs in response to the activity gradient defined by 
unbound chemical concentrations in the tubular fluid and in plasma.  For neutral 
chemicals that diffuse easily across biological membranes, there may be substantial 
reabsorption driven by reabsorption of filtered plasma (including water and small ionic 
constituents).  In such cases, the CLR may be much less than the GFR.  Because they 
are largely ionized, PFAAs do not diffuse easily across membranes.  We would therefore 
expect little passive reabsorption once they appear in the proximal tubule. 
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Membrane transporters are expressed on both the basolateral (lumen) and apical 
(plasma) side of cells that form the proximal tubule.  These proteins may facilitate the 
movement of chemicals down their electrochemical gradient (facilitated transport) or 
promote their movement against an electrochemical gradient (active transport).  There 
are two basic mechanisms of active transport.  The first derives energy from the 
hydrolysis of ATP (primary mechanism) while the second relies on energy-requiring 
processes to produce a chemical gradient that is coupled to the movement of another 
compound (secondary mechanism).  Renal transporters may actively secrete chemicals 
into the tubular fluid or promote their reabsorption into plasma.  Both processes appear 
to be important in understanding species and sex differences in renal elimination of 
PFAAs, especially for those differences noted to be under the control of sex hormones. 
In vivo evidence for the importance of renal transport as a determinant of PFAA 
kinetics developed out of the observations of marked sex and species differences in 
renal elimination.  Vanden Huevel et al. (1992) noted that treatment of both female and 
castrated male rats with probenecid, a uric acid reuptake inhibitor believed to block 
organic anion transport (OAT) proteins in the kidney, decreased renal elimination of 
PFOA.  In contrast to these findings, there were no significant effects of probenecid on 
PFOA elimination in intact male rats (which eliminate PFOA more slowly than female 
rats) treated with sham surgery.  These results led to the conclusion that expression of 
transporters responsible for sex-specific differences in PFOA elimination in rats was 
likely to involve OATs and was at least partially controlled by testosterone.  Other in vivo 
studies of PFOA transport include a rat knockout model used to rule out a significant role 
for Mrp2 in PFOA transport in rats (Katakura et al., 2007).  This study also determined 
that a low-phosphate diet, which increased the expression of an organic phosphate 
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transporter, reduced PFOA clearance in rats.  This was presumed to be due to the 
promotion of reuptake.  Han et al. (2012) analyzed a number of whole-animal studies to 
characterize net transport of PFOA in the renal tubule.  Net transport, either positive 
(dominated by secretion) or negative (dominated by reuptake) was determined by the 
relationship: CLS – CLABS = CLR – fu * GFR, where CLS is the tubular secretion rate 
(ml/kg/d), CLABS is tubular reabsorption rate (ml/kg/d), and fu is the unbound fraction of 
PFOA in plasma (unitless).  Net secretion was found to occur in rabbits and female rats.  
In other species, including male rats, dogs, mice, humans, and nonhuman primates, 
reabsorption predominated.   
Based on earlier observations of sex-related differences in PFOA elimination in 
rats, Kudo et al. (2002) conducted a study in which reverse-transcription polymerase 
chain reaction (RT-PCR) was used to quantify the mRNA of a number of candidate 
transporters for PFOA in male, female, ovariectomized female, and castrated male rat 
kidney tissue.  The results showed that Oat2 and Oat3 were both likely candidates.  A 
number of in vitro and cell based studies have been performed to identify proteins that 
that may play a role in membrane transport of PFAAs (Han et al., 2008; Katakura et al., 
2007; Nakagawa et al., 2008, 2009; Weaver et al., 2010; Yang et al., 2010; Zhao et al., 
2017).  Transporters associated with reuptake of PFAAs from urine into kidney proximal 
tubular cells include OAT4 and URAT (Yang et al., 2010) in human cells.  Yang et al. 
(2009) used a culture of Chinese Hamster Ovary (CHO) cells transfected with rat 
Oatp1a1 to show that Oatp1a1 increased uptake of PFOA with saturable kinetics and 
that this uptake was subject to competitive inhibition by other transporter substrates.  
Several transporters, including human OAT1 and OAT3, as well as their rat orthologs 
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Oat1 and Oat3, were determined to increase uptake from blood into proximal tubular 
kidney cells (Han et al., 2012).  
Nearly all of the transporters known to be associated with PFAA transport in the 
kidney are members of the solute carrier family (SLC) of proteins, and operate via a 
secondary active mechanism (e.g. OATs/Oats).  However, ATP binding cassette (ABC) 
transporters, acting as efflux pumps may play a role as well (Han et al., 2012).  This is 
important, as the transporters that have been associated with PFAA transport thus far 
have been associated with uptake, from either urine or plasma, into kidney proximal 
tubular cells (though some of these transporters are potentially bidirectional).  Because 
the kidney is not a site of extensive PFAA accumulation, and because some species and 
sexes are believed to actively excrete some PFAAs, it is assumed that efflux 
transporters operate on both the apical (urine side) and basolateral (blood) side cell 
membranes.  Finally, studies of renal transport of PFAAs have been primarily focused on 
carboxylate PFAAs, however, sulfonates are also believed to be substrates for renal 
transport, as has been demonstrated in liver and intestine (Zhao et al., 2017). 
PFAA Kinetics in Fish 
Prior to the work described in this dissertation, the only published studies of 
PFAA kinetics in fish were those given by Martin et al. (2003a, 2003b), De Silva et al. 
(2009), and Lee and Schultz (2010).  The studies performed by Martin et al. (2003a, 
2003b) were published as companion papers.  One paper (Martin et al., 2003a) 
described the dietary accumulation of eleven PFAAs in small (2-5 g) rainbow trout 
(Oncorhynchus mykiss), while the second (Martin et al., 2003b) described the 
bioconcentration of these same chemicals in somewhat larger trout (5-10 g) following a 
continuous aqueous exposure.  Included among the chemicals tested were PFOS and 
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PFOA.  Both studies employed an experimental design which provided uptake and 
elimination data, and both sought to collect information needed to estimate relevant 
metrics of bioaccumulation. 
 Estimated dietary absorption efficiencies, determined by modeling to measured 
whole-body PFAA concentrations, ranged from 59% for PFOA to 100% for a number of 
other PFAAs, including PFOS (Martin et al., 2003a).  As such, these findings indicate 
that PFAAs consumed by fish are taken up with high efficiency.  Fitted rate constants 
(kU) for branchial uptake in waterborne exposures ranged from 0.53 L/kg/d for PFOA to 
700 L/kg/d for perfluorododecanoic acid (PFDoA; Martin et al., 2003b).  The distribution 
of PFAAs to various tissues followed the same general pattern noted previously in 
studies with mammals (Martin et al., 2003a).  Thus, the highest concentrations were 
found in plasma, liver, and kidney, while substantially lower concentrations were 
measured in muscle, gonads, gill tissues, and adipose fat.  
Both studies performed by Martin et al. (2003, 2003b) demonstrated that the T½ 
of PFAAs in trout varies with carbon chain length and the identity of the acidic moiety.  In 
the bioconcentration study, whole-body T½ values ranged from 5.2 days for PFOA to 28 
days for perfluorotetradecanoic acid (PFTA; Martin et al., 2003b).  When combined with 
modeled rates of branchial uptake, these measured elimination rates corresponded to 
bioconcentration factors (BCFs) ranging from 4 (PFOA) to 23,000 (PFDoA).  Importantly, 
the BCF determined for PFOS was 1100, which just meets the regulatory criteria (BCF > 
1000) used by US EPA to identify “bioaccumulative” substances (Gobas et al., 2009).  
When regressed against carbon chain length, T½ values for the carboxylate PFAAs 
increased in a roughly linear manner.  Plotted against this linear relationship, T½ values 
for the sulfonate PFAAs were well above the line, indicating a reduced rate of elimination 
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relative to carboxylate PFAAs for a given carbon chain length.  Elimination half-lives 
measured in the dietary accumulation study were similar to those determined following 
waterborne exposures, and calculated biomagnification factors (BMFs; referred to by the 
authors as BAFs) ranged from 0.04 for PFOA to 1.0 for PFDoA (Martin et al., 2003a).   
Using a dietary exposure protocol similar to than employed by Martin et al. 
(2003a), De Silva et al. (2009) dosed juvenile (~30 g) rainbow trout with a mixture of 
branched and linear PFOA isomers, n-perfluorononanoate (n-PFNA), and isopropyl 
PFNA.  In general, fish tended to accumulate linear isomers of PFOA and PFNA to a 
greater extent than branched structures.  Consistent with these findings, T½ values for 
the linear structures were longer that T½ values for branched structures containing the 
same number of fluorinated carbons.  In a separate study, De Silva et al. (2009) dosed 
trout with a lower concentration of PFOA than that used in the initial mixture study.  
Recognizing the potential importance of renal transport as a route of elimination for 
PFAAs, the authors hypothesized that the elimination kinetics of PFOA may be dose-
dependent.  However, no such effect was seen.  Lee and Schultz (2010) exposed male 
and female fathead minnows (Pimephales promelas) to PFOA in the diet and then 
allowed the fish to depurate.  The T½ for males was 68.5 hours, while that for females 
was 6.3 hours.  Treatment of females with an androgen (17-β-trenbolone) increased the 
T½ to 25.3 hours.  In contrast, treatment of males with an estrogen (ethinylestradiol, EE) 
had no apparent effect on PFOA elimination.  This study is important because it 
demonstrated reversible sex differences in PFOA elimination in fathead minnows, 
analogous to that observed in mammals.  In addition, it suggested that elimination of 
PFOA in fatheads is under androgenic control. 
Bioaccumulation Assessment for PFAAs in Fish 
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In 2001, a coalition of nations organized through the United Nations Environment 
Program (UNEP) signed a treaty regarding twelve synthetic chemicals, of which nine 
were to be banned, and a tenth (DDT) restricted to use (though not banned) in malaria 
control programs (Gobas et al., 2009; UNEP, 2001).  Of special concern was the 
potential for these compounds to distribute in the environment by long-range transport.  
As of 2016, this agreement, known as the Stockholm Convention on Persistent Organic 
Pollutants (POPs), had been signed and ratified by 179 individual entities and the 
European Union, with the most notable exception being the United States.  All chemicals 
on the “dirty dozen” list exhibit a tendency to persist in the environment, high potential for 
bioaccumulation, and substantial toxicity.  The Stockholm Convention was largely 
motivated by a desire to protect human health; however, the potential for environmental 
harm is considered.  Signatories may nominate chemicals for addition to the Stockholm 
Convention under three Annexes (A-C), which represent varying degrees of action.  
PFOS and a precursor were added to the list of restricted compounds (Annex B) at a 
fourth Conference of the Parties in 2009 (UNEP, 2009).  This designation requires that 
all parties take measures to restrict the production and use of PFOS “in light of any 
applicable acceptable purposes and/or specific exemptions.” 
Consistent with the goals of the Stockholm Convention, a number of jurisdictions 
have (in many cases, previously) developed legislation which mandates the evaluation 
and classification of commercial chemicals.  Examples include the Toxic Substance 
Control Act (TSCA), which is the major piece of United States legislation that deals with 
industrial compounds (US EPA, 1976, 2016), the Canadian Environmental Protection 
Act (CEPA, 1999), and the European Registration, Evaluation and Authorization of 
Chemicals (REACH) legislation (Council of European Union, 2006).  Under each of 
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piece of legislation, compounds meeting criteria for persistence, bioaccumulation, and 
toxicity (i.e., “PBT compounds”) are subject to further assessment to determine their 
potential for causing adverse human and environmental effects.      
 Chemicals may accumulate in both terrestrial and aquatic organisms.  However, 
the focus of most bioaccumulation assessments is on chemical accumulation in fish.  
This focus acknowledges the well-documented tendency of hydrophobic organic 
chemicals to partition out of water and into fish tissues, posing a threat to these animals 
and the animals that consume them.  A number of definitions have been developed to 
qualify and quantify the tendency for chemicals to accumulate in fish.  When used in this 
context, the term “bioaccumulation” refers to chemical accumulation in an organism 
occurring by all routes of exposure.  This term is best understood in the context of an 
environmental setting where multiple routes of exposure (e.g., dietary, inhalation, 
dermal) are likely.  Chemical accumulation that occurs during a water-only exposure is 
termed “bioconcentration.”  Dermal uptake may contribute substantially to chemical 
bioconcentration in very small fish and the young of larger species.  For fish that exceed 
about 1 g in size, dermal uptake becomes negligible and chemical uptake from water 
occurs primarily at the gills (Lien and McKim, 1993).  The concept of bioconcentration 
may apply to an environmental setting where uptake by non-respiratory routes of 
exposure is negligible.  More commonly, however, it applies to controlled waterborne 
exposures performed in a laboratory testing environment.  Another key concept is 
chemical “biomagnification.”  This term refers to the tendency for chemical 
concentrations in tissues to increase at successively higher trophic levels.  
 Bioaccumulation, bioconcentration, and biomagnification in fish are typically 
quantified in terms of “factors.”   The BCF describes the ratio of the chemical 
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concentration in biota (tissues or whole-body) to that in water, achieved in a water-only 
exposure (Gobas et al., 2009; Weisbrod et al., 2009).  Because it is most often based on 
controlled laboratory exposures, the BCF is generally assumed to represent steady-state 
conditions.  The bioaccumulation factor (BAF) describes the ratio of the chemical 
concentration in biota to that in water, where accumulation occurs by all possible routes 
of exposure.  BAFs based on measured residues in field collected animals may or may 
not represent steady-state conditions, while modeled BAFs generally reflect this 
assumption.  Hydrophilic and moderately hydrophobic compounds (log KOW < 4) are 
taken up by fish primarily across the gills.  For such compounds, the laboratory BCF is 
expected to be close to the field BAF (measured or modeled).  For more hydrophobic 
compounds, the field BAF may exceed the laboratory BCF due to the contribution of 
dietary uptake (Gobas and Morrison, 2000).  The BMF relates the ratio of the chemical 
concentration in biota to the concentration in its diet.  For hydrophobic compounds, the 
lipid content of a fish strongly determines its capacity to accumulate chemical.  For this 
reason, BMFs are frequently calculated based on lipid-normalized chemical 
concentrations in the predator and its prey.  Calculated in this manner, a BMF > 1 
indicates that the chemical concentration in a predator exceeds that which would have 
been predicted had the predator and its prey come to thermodynamic equilibrium. 
Predictive models for bioaccumulation and bioconcentration assessment 
Field and laboratory studies designed to measure chemical accumulation in fish 
are numerous and ongoing.  In general, however, the need to evaluate bioaccumulation 
potential in support of legislated hazard assessments is much greater than existing 
testing capabilities.  Moreover, there is increasing pressure in Europe and elsewhere to 
limit these testing activities as part of the “3Rs” approach (replacement, reduction, 
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refinement) to ethical use of live animals (European Union, 2010; Goodman et al., 2015).  
For these reasons, most bioaccumulation assessments are performed using predictive 
computational models, alone or in combination with in vitro methods (Nichols et al., 
2009).  
Quantitative Structure Activity Relationship (QSAR) models that predict chemical 
bioconcentration in fish have been widely used since the late 1970s (Pavan et al., 2008; 
Nichols et al., 2009).  These models vary in complexity; however, all are based on the 
well-known pattern that exists between measured BCFs and chemical hydrophobicity, 
typically expressed as the log of a compound’s n-octanol/water partition coefficient (log 
KOW; Devillers et al., 1998; Nichols et al., 2009).  More specifically, it was discovered that 
the log of the BCF for many neutral chemicals increased linearly with chemical log KOW 
up to a log KOW value of approximately 6.  At higher log KOW values, log BCFs tended to 
level off or even decrease (Meylan et al., 1999).  The rationale given for this relationship 
is that log KOW is a quantitative surrogate for chemical partitioning to tissue lipids, which 
is considered to be a key process underlying most observed bioaccumulation (Nichols et 
al., 2009).  At very high log KOW values, log BCFs decline because chemical 
bioavailability in water is reduced by non-specific binding to dissolved and particulate 
organic carbon.  This has the effect of reducing the “free” or unbound concentration with 
which the animal comes to equilibrium.  
Chemical accumulation in fish may also be predicted using mechanistic mass-
balance models.  Generally, these models represent the fish as a single well-stirred 
compartment, and the processes that control chemical uptake and elimination are 
described by first-order rate constants (Gobas and Morrison, 2000; Arnot and Gobas, 
2003, 2004).  Many of the inputs to these models, including rate constants for chemical 
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flux across the gills, may be estimated from KOW-based relationships.  Other terms, such 
as water temperature and the fish’s lipid content, are tailored to a particular species and 
exposure scenario.  These models can be expanded to describe chemical uptake and 
elimination in the gastrointestinal tract.  As such, they may be used to predict chemical 
BCFs or BAFs.  When incorporated into an appropriate food web model, such 
descriptions may also be used to predict chemical BMFs.  
Multi-compartment mass-balance models for fish have also been provided, 
including physiologically based toxicokinetic (PBTK) descriptions that predict chemical 
uptake and accumulation from physiological, biochemical, and physio-chemical 
information (Nichols et al., 1990).  Within such models, KOW may play an important role 
as a predictor of chemical flux at various exchange surfaces (e.g., gills, gut and skin), as 
well as partitioning to blood and tissues.  PBTK models are now gaining increased 
acceptance as tools for chemical bioaccumulation assessment (Stadnicka et al., 2014; 
Brinkman et al., 2016).  Because they describe chemical accumulation in specific tissues 
and organs, PBTK models are well suited for relating in vitro effects information to 
exposures that would be required to elicit these effects in vivo (an application commonly 
referred to as “reverse toxicokinetics”). 
Existing QSAR and mass-balance models have been shown to accurately predict 
observed levels of bioconcentration and bioaccumulation in fish for a broad range of 
substances (Nichols et al., 2009).  Nevertheless, both model types are subject to errors.  
One potential source of error in modeled predictions is chemical biotransformation.  
QSAR models do not generally consider the possibility of biotransformation.  When this 
activity occurs in fish, these models tend to overestimate true levels of accumulation 
(Oliver and Niimi, 1985; Clark et al., 1990; de Wolf et al., 1992).  Mass-balance models 
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may incorporate one or more metabolism rate constants; however, they tend to be quite 
sensitive to the specified value(s) of this(ese) term(s), which may vary widely between 
chemicals, organisms, and exposure conditions.  A second potential source of error in 
current predictive models relates to chemical transport across biological membranes.  In 
general, these models assume (explicitly or implicitly) that chemical flux across biological 
membranes occurs by simple passive diffusion.  Restricted diffusion across membranes 
is likely for very high molecular-weight and/or extremely hydrophobic compounds 
(Nichols et al., 2009), as well as compounds that ionize at physiological pH values 
(Armitage et al., 2017).  Finally, both model types generally ignore the possible role of 
membrane transport proteins which may promote chemical uptake or elimination, 
depending on their activities and the tissues in which they are expressed. 
Applicability of current models for predicting PFAA bioaccumulation 
The use of traditional KOW-based models to predict bioaccumulation of PFAAs in 
fish is problematic for several reasons.  First, because they are somewhat lipophobic, 
PFAAs do not preferentially partition to tissue lipids.  Instead, they bind to specific 
proteins in blood plasma and selected tissues (e.g., liver and kidney).  A second problem 
is that KOW can’t be directly measured for these compounds, as PFAAs are surfactants 
which tend to partition to the octanol-water interface, though QSAR methods may be 
used to predict KOW values.  Also, because the PFAAs are virtually 100% ionized at 
physiological pH values, simple diffusion across biological membranes is likely to be 
highly restricted.   
To date, three models have been developed to describe the accumulation of 
PFAAs in fish.  The first, given by Webster and Ellis (2010), described this accumulation 
using a modification of the traditional QSAR KOW-based approach, where the BCF is 
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predicted from chemical KOW and a fish’s fractional lipid content.  For this application, the 
standard BCF QSAR was modified to incorporate the Hendersen-Hasselbach 
relationship, which predicts ionized and neutral fractions of a chemical from pH and the 
chemical’s pKa value.  This approach yields a BCF which is corrected to account for 
partitioning of only the neutral fraction of a PFAA.  When this model was applied to the 
chemicals tested by Martin et al. (2003a, 2003b), predicted BCFs were in reasonably 
good agreement with measured values.  However, the pKa value used to parameterize 
the model (3.8) is probably much higher than true values (generally thought to be 1.0 or 
lower; Moroi et al., 2001; Goss et al., 2008; Cheng et al., 2009).  As such, this model is 
highly suspect.         
A second model, given by Armitage et al. (2013), is a modification of the one-
compartment KOW-based model given by Arnot and Gobas (2004), and was developed 
as a generalized description for ionizable substances.  The model predicts the 
accumulation of ionized chemicals by fish from KOW-based binding to tissue 
phospholipids, and employs a gill uptake description which accounts for restricted 
uptake of ionized forms from water.  Renal clearance as a route of elimination was not 
considered.  Model performance for PFAAs was highly dependent on the specification of 
pKa and KOW.  Regardless of which values were chosen, however, the model could not 
explain the large observed differences in measured BCFs for PFOS and PFOA.  Finally, 
it may be questioned whether this type of model is appropriate for simulating the 
accumulation of PFAAs, given their known affinity for specific proteins and not 
membrane phospholipids. 
A mechanistic model for PFAAs in fish was provided by Ng and Hungerbühler 
(2013).  Unlike the models given by Webster and Ellis (2010) and Armitage et al. (2013), 
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this model contains a number of features which reflect current knowledge regarding 
factors that control uptake, distribution, and elimination of PFAAs in mammals.  Within 
this model, the fish is described as a collection of compartments corresponding to 
tissues (cells) and tissue interstitial fluids which contain relevant binding proteins.  Owing 
to the lack of mechanistic data for fish, the model was extensively parameterized using 
information from mammals.  Thus, mammalian data was relied upon to describe PFAA 
binding to albumin and fatty acid binding proteins, while transfer rates across the gills 
were based on diffusion rates measured in mammalian in vitro cell cultures.  Similarly, 
modeled rates of renal secretion and reabsorption were based on the measured 
activities of rat membrane transporters (Oats, Oatps, and Urat) which had been 
transfected into various mammalian cell lines.  The model was largely successful in 
predicting the tissue distribution of PFAAs studied by Martin et al. (2003b), at least in 
terms of relative concentrations, though it tended to under-predict measured kidney and 
plasma concentrations.  Of particular interest to the studies described in this dissertation, 
the authors noted that their model was hampered by a lack of information regarding 
renal elimination of PFAAs in fish. 
Study Goals and Objectives 
 Concern regarding potential adverse effects of PFAAs on human health and the 
environment derives from the historical scope of PFAA production and use, and the 
demonstration that PFOS, PFOA, and other long-chain PFAAs can persist in the 
environment and accumulate in biota.  Though initially regarded as biologically inert, 
accumulating evidence suggests that some PFAAs are toxic, particularly in repeated 
exposures.  In mammals, toxicity associated with an individual PFAA may vary 
substantially between species and between the sexes within a species.  These 
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differences appear to be correlated with the ability of different organisms to eliminate 
these compounds, as indicated by differences in T½.  Additional studies have shown that 
difference in T½ are largely due to differences in CLR.  Differences in CLR are due, in 
turn, to differences in the expression and activities of renal membrane transporters 
which secrete PFAAs into urine and promote their reuptake into plasma. 
 Numerous field surveys have shown that PFAAs in the environment accumulate 
in fish and the animals that consume fish, including aquatic-dependent birds and 
mammals.  Additional, limited studies indicate that PFAAs may exert adverse effects on 
fish via toxicity pathways similar to those observed in mammals.  The extent to which 
individual PFAAs accumulate in fish varies widely; in general, the greatest extent of 
accumulation is observed for longer chain PFAAs, and (for a given perfluorocarbon 
chain length) for sulfonates.  Shorter chain PFAAs exhibit little or no tendency to 
bioaccumulate.  As in mammals, difference in accumulation are associated with 
differences in T½.  However, the mechanistic basis for these observed differences in T½ 
has been poorly understood.  
The primary goal of studies described in this dissertation was to obtain a detailed 
mechanistic understanding of PFAA uptake and elimination in fish, while the larger aim 
was to support ongoing development of mechanistic models used to predict PFAA 
accumulation in fish.  The working hypothesis, based on previous research with 
mammals, was that renal elimination contributes substantially to PFAA elimination in 
fish, and that differences in renal elimination are a primary determinant in differences in 
bioaccumulation of individual PFAAs.  These investigations were performed using the 
two most well-studied PFAAs, PFOS and PFOA.  Previous work has shown that PFOS 
exhibits a marked tendency to accumulate in fish while PFOA does not.      
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Detailed kinetic studies with PFOS and PFOA were performed with large, 
chambered trout using methods developed by McKim and Goeden (1982).  The 
experiments were conducted at the US EPA research facility in Duluth, MN (US 
EPA/NHEERL/Mid-Continent Ecology Division) using exposure facilities which are 
unique with respect to the surgical preparation of study animals, control of chemical 
dosing, and collection of supporting physiological information.  Individual animals were 
instrumented to permit repeated sampling of plasma, urine, and expired water.  Dosing 
was performed by injecting animals with a bolus dose of chemical (to characterize 
elimination) or by introducing the chemical to respired water (to characterize branchial 
uptake).  The resulting datasets were analyzed using a two-compartment clearance-
volume kinetic model.  Importantly, this modeling approach makes no assumptions 
regarding factors which influence a compound’s apparent volume of distribution.  As 
such, it does not rely on potentially problematic specification of chemical KOW.  
Moreover, kU and CLR values determined in this manner may be compared directly to 
existing physiological information for trout, including the volumetric flow rate of water 
across the gills, renal blood flow, GFR, and urine flow rate. 
Chapter 2 of this dissertation, which was published in Aquatic Toxicology 
(Consoer et al., 2014), describes the kinetics of PFOA in trout.  Chapter 3, which was 
published in Environmental Toxicology and Chemistry (Consoer et al., 2016) describes 
the kinetics of PFOS in trout.  Data and fitted model simulations for individual study 
animals are provided at the end of each chapter.  Additional supporting information in 
Chapter 2 describes preliminary studies which were performed to ensure that blood and 
urine could be sampled without loss of PFOA to blood cannulas and urine catheters.  
Chapter 4 contrasts and compares the major findings these two kinetic studies, and 
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relates this information to existing knowledge regarding the kinetics of PFAAs in 
mammals (Chapter 1).  Concluding sections of Chapter 4 discuss the implications of 
these findings for bioaccumulation assessment of PFAAs in fish, and provide guidance 
on future research directions. 
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Chapter 2: Toxicokinetics of perfluorooctanoate (PFOA) in rainbow trout 
(Oncorhynchus mykiss) 
Daniel M. Consoer, Alex D. Hoffman, Patrick N. Fitzsimmons, Patricia A. Kosian, John 
W. Nichols.   
Published in Aquatic Toxicology, 12 May, 2014. Volume 156, p 65-73. 
Abstract 
  Rainbow trout (Oncorhynchus mykiss) confined to respirometer-metabolism 
chambers were dosed with perfluorooctanoate (PFOA) by intra-arterial (i.a.) injection 
and sampled to obtain concentration time course data for plasma, urine, and expired 
water.  The data were then analyzed by compartmental modeling to estimate rates of 
renal and branchial clearance.  Averaged across all animals, the renal clearance rate 
(1.35 mL/h/kg) was more than ten times greater than the branchial clearance rate (0.12 
mL/h/kg).  The average whole-body elimination half-life was 12.6 d, which is somewhat 
longer than values obtained in previous studies with smaller trout.  The tissue distribution 
of PFOA was assessed by collecting tissues at the end of chambered exposures and in 
a separate tissue time-course experiment.  From the time-course study it appeared that 
an internal steady-state was established within 24 h of i.a. injection.  Consistent with 
previous studies, the rank order of PFOA concentration in tissues at steady state was: 
plasma > liver > kidney > muscle.  In a second set of chambered experiments, fish were 
exposed to PFOA in water to determine the rate of branchial uptake.  Branchial uptake 
rates were too low to assess directly by measuring PFOA concentrations in inspired and 
expired water.  Uptake rate constants (mean 0.19 L/d/kg; 0.1% uptake efficiency) were 
therefore estimated by compartmental modeling using plasma concentration time-course 
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data and model parameters derived from the elimination experiments.  It is clear from 
this effort that elimination of PFOA by trout occurs primarily via the renal route.  This 
finding is consistent with numerous studies of mammals and suggests that trout possess 
membrane transporters that facilitate the movement of PFOA from plasma to urine. 
1. Introduction 
Perfluoroalkyl acids (PFAAs) are used in stain-resistant coatings, and as 
surfactants, fire-fighting foams, and photographic developers (Lau et al., 2007; Renner, 
2001).  Concern that these chemicals may constitute an important class of 
environmental contaminants can be traced back to 2001, when Giesy and Kannan 
(2001) published their findings on the global distribution of perfluorooctane sulfonate 
(PFOS) in wildlife.  Since then, PFAAs have been measured in humans, surface waters, 
and aquatic sediments, and have been found in environmental matrices far from any 
known sources (Prevedouros et al., 2006).  Although initially thought to be biologically 
inert, several PFAAs have been shown to cause toxic effects in mammals, including 
developmental toxicity, immunotoxicity, and hepatotoxicity (Andersen et al., 2008; Lau et 
al., 2004, 2007).  Toxicity studies with fish have largely, though not solely focused on 
PFOS as a model compound.  These investigations have demonstrated reproductive 
effects (Han and Fang, 2010), developmental toxicity (Han and Fang, 2010; Huang et 
al., 2010; Shi et al., 2008), hepatotoxicity (Hoff et al., 2003; Wei et al., 2008a, 2008b) 
and behavioral effects (Huang et al., 2010).  Individual PFAAs have been shown to 
accumulate in aquatic species, although the extent of this accumulation varies widely.  
Measured log bioaccumulation factors (BAFs) for six PFAAs in Great Lakes lake trout 
(Salvelinus namaycush) ranged from 2.7 for perfluorohexane sulfonate (PFHxS) to 4.1 
for PFOS (Furdui et al., 2007).  Liu et al. (2011) reported BAFs for green mussels (Perna 
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viridis) ranging from 15 for perfluoroctanoate (PFOA) to 859 for perfluorodecanoate 
(PFDA), along with evidence for dependence of these values on the exposure 
concentration.  In general, the tendency of individual PFAAs to accumulate in fish is 
directly related to the length of a compound’s fluorinated carbon chain as well as the 
identity of the terminal group (sulfonate or carboxylate), which confers to the molecule its 
amphipathic character.  PFOA and other shorter chain carboxylates accumulate to a 
lesser extent than perfluorosulfonates of comparable chain length, to the point that they 
are not considered to be bioaccumulative based on standard regulatory criteria (e.g., 
BAF > 1000; Martin et al., 2003a, 2003b; Conder et al., 2008).  
Models commonly used to predict the accumulation of lipophilic chemicals in fish 
are generally thought to be inadequate for PFAAs.  Such models describe uptake and 
accumulation as a consequence of passive diffusion across the gills and gut, and 
subsequent partitioning to whole-body lipid, taking into consideration the possibility of 
biotransformation (Arnot and Gobas, 2004).  It is well known, however, that PFAAs do 
not partition to tissue lipid but instead bind to protein.  Moreover, the character of this 
binding suggests high affinity for specific protein sub-classes including serum albumin 
and fatty-acid binding proteins in the liver (Han et al., 2003; Ng and Hungerbühler, 
2013).  Thus, PFAAs exhibit little tendency to accumulate in the white muscle of fish, 
which constitutes by far the largest store of total whole-body protein, and instead 
accumulate in blood plasma, liver, and kidney (Martin et al., 2003a).  Complicating 
matters further, PFAAs are ionogenic and exist as a mixture of charged and neutral 
species.  Uptake, distribution, and elimination are likely to depend, therefore, on an 
individual compound’s pKa and the pH of the local environment. 
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In mammals, large differences in the biological half-life of specific PFAAs have 
been noted for different test organisms (Butenhoff et al., 2004a; Andersen et al., 2008; 
Han et al., 2012).  These differences have been attributed to different rates of renal 
elimination (Andersen et al., 2006; Butenhoff et al., 2004b; Han et al., 2012) which are 
due, in turn, to differences in the activities of specific transporters including the organic 
anion transporters Oat1 and Oat3, the organic anion transporting polypeptide Oatp1a1, 
and uric acid transporter 1 (Urat1), all of which facilitate reuptake of PFAAs from renal 
filtrate in the proximal tubule (Kudo et al., 2002; Nakagawa et al., 2008; Weaver et al., 
2010).  The presence/absence and activities of these transporters are also thought to 
explain large differences in elimination that often exist between the sexes, as the 
expression of many renal transporters is known to be under the control of sex hormones 
(Cheng and Klaassen, 2009; Ljubojevic et al., 2007; Morris et al., 2003). 
Recent efforts to model PFAA accumulation in fish have attempted to account for 
some or all of these characteristic behaviors.  For example, a model given by Armitage 
et al. (2013) predicts the uptake and accumulation of PFAAs based on partitioning of 
neutral and ionized chemical species to both neutral lipids and phospholipids.  This 
model does not, however, account for the possible role of renal clearance.  A second 
model, given by Ng and Hungerbühler (2013) explicitly describes protein binding 
interactions in several tissue compartments and includes a renal clearance description 
which operates against the unbound chemical mass in kidney tissue.  Model terms that 
describe renal elimination were based on data from studies with mammals, as data for 
fish were lacking. 
Given the importance of PFAAs as a class of environmental contaminants as well 
as the need to advance current modeling efforts, it is critical to obtain mechanistic 
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information regarding the kinetics of these compounds in fish, and in particular data 
regarding renal clearance.  Although direct evidence for renal elimination of PFAAs in 
fish is lacking, indirect evidence suggests that it may play a role in the elimination of 
some compounds.  For example, Lee and Schultz (2010) suggested that differences in 
renal elimination may have accounted for observed sex-linked differences in elimination 
of PFOA by fathead minnows.  The goal of the present study was to characterize the 
routes and rates of PFOA elimination in large rainbow trout which had been chronically 
catheterized to permit continuous collection of urine.  Additional experiments were 
performed to evaluate the uptake of PFOA across trout gills and the kinetics of its 
distribution to tissues. 
2. Materials and methods 
2.1. Chemicals  
PFOA (>98% pure) was purchased from Sigma Aldrich (St. Louis, MO).  PFOA 
and mass-labeled [13C] PFOA standards were purchased from Wellington Laboratories 
(Guelph, ON, Canada).  HPLC grade acetonitrile, methanol, and glacial acetic acid were 
purchased from Fisher Scientific (Pittsburgh, PA).  
2.2. Animals  
Rainbow trout (Oncorhynchus mykiss) weighing approximately 100 g were 
obtained from the USGS Upper Midwest Environmental Sciences Center in La Crosse, 
WI, and grown up to the desired size for each experiment.  The animals were held in 
sand-filtered Lake Superior water at 11 ± 1 ºC under a natural photoperiod and fed a 
commercial trout chow (Silver Cup, Nelson and Sons Inc., Murray, UT).  Water chemistry 
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characteristics were: total hardness 45–46 mg/L as CaCO3; alkalinity 41–44 mg/L as 
CaCO3; pH 7.6–7.8; total ammonia < 1 mg/L; dissolved O2 85–100% of saturation. 
2.3. Surgical preparation of animals  
Elimination and branchial uptake studies were performed using trout confined to 
respirometer-metabolism chambers (McKim and Goeden, 1982).  All of these fish had 
gone through at least one spawning cycle prior to use, and varied with respect to their 
state of sexual maturity at the time of data collection.  Fish weighing 700–1500 g were 
sedated with tricaine methanesulfonate (MS- 222; Finquel, Argent Laboratories, 
Redmond, WA), weighed, and placed on a surgical table designed to provide continuous 
anesthesia with temperature-controlled, oxygenated water.  Each fish was immobilized 
by spinal transection and surgically fitted with a dorsal aortic cannula (Intramedic PE 50; 
Becton, Dickinson and Co., Parsippany, NJ) to permit periodic blood sampling.  Fish 
used for elimination experiments also were fitted with a urinary catheter (Intramedic PE 
90) for continuous collection of urine.  A latex membrane sewn to the fish’s mouth 
allowed separate collection of inspired and expired water.  A second latex membrane 
just posterior to the pectoral fins prevented further dilution of expired water.  Fish were 
allowed 24 h to recover from surgery before starting an experiment.  Water temperature 
(T; ºC), ventilation volume (VVOL; mL/min), and oxygen consumption (VO2; mg/h/kg) were 
monitored continuously using an automated data collection system and customized 
software (Carlson et al., 1989).  This information was then evaluated to assess the 
viability and representativeness of each preparation, and generate average values for 
the experimental time period.  
2.4. Elimination experiments 
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Eight trout of mixed sex were given a bolus intra-arterial (i.a.) injection of PFOA 
dissolved in trout serum (1 mL/kg), with each fish receiving a nominal dose of 1.0 mg/kg, 
equivalent to approximately 2 µmol/kg.  Blood, urine, and expired water were sampled 
periodically for 72 h to evaluate the kinetics of PFOA in plasma and characterize its 
elimination by renal and branchial routes.  Blood samples (100 µL) were centrifuged at 
6000 RCF for 6 min (10 ºC) to obtain plasma.  Expired water (1 L) was withdrawn 
directly from the respirometer-metabolism chamber.  Urine samples (50–100 µL) were 
collected into pre-weighed 1.5-mL microcentrifuge tubes via the renal catheter.  These 
tubes were then reweighed to obtain the mass of urine collected.  The volume of urine 
produced between sampling times was recorded to calculate the urine flow rate (UFR) 
for each time period as well as an average UFR for the entire experiment. 
Fish were euthanized after the final sampling period with an overdose of MS-222, 
and samples of kidney, liver, muscle, and bile were collected and stored at −20 ºC for 
later analysis.  Muscle was sampled from above the lateral line, anterior to the dorsal fin. 
The liver, kidney, and bile were collected in their entirety.  
2.5. Branchial uptake experiments  
By providing for separate collection of inspired and expired water, respirometer-
metabolism chambers allow for direct measurement of chemical uptake across the gills 
(McKim and Goeden, 1982).  In practice, however, this method depends on there being 
a discernible difference in chemical concentration between inspired and expired water, 
taking into account the variance associated with these measurements.  Alternatively, 
branchial uptake can be estimated indirectly by modeling to measured chemical 
concentrations in plasma, provided that the model adequately accounts for the internal 
distribution of a compound as well as its elimination by non-branchial routes. 
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Eight trout of mixed sex were exposed to PFOA in water for 72 h.  Fish were 
surgically prepared as described above with the exception that they were not fitted with a 
urinary catheter.  A stock solution of PFOA was prepared by dissolving PFOA in de-
ionized water (Milli-Q; EMD Millipore, Billerica, MA).  The stock solution was metered 
into a mixing cell and diluted with Lake Superior water to achieve a nominal target 
concentration of 500 µg/L.  This water was then supplied to each chambered animal in 
excess of its respiratory requirement (approx. 440 mL/min).  Blood samples (100 µL) 
were obtained at 2, 4, 8, 24, 36, 48, 54, and 72 h, and processed as described above. 
Tissue samples (liver, kidney, muscle) were again collected at test termination and 
stored at −20 ºC for later analysis.  
2.6. Tissue distribution study  
Sixteen trout of mixed sex weighing 150–250 g were given a bolus i.a. injection 
of PFOA to study the tissue distribution time course.  All of these animals were sexually 
immature juveniles that had not yet gone through a spawning cycle.  Fish were given a 
nominal dose of 1 mg/kg dissolved in trout plasma (2 mg/mL, administered at 0.5 mL/kg 
injection volume).  Animals were sedated with MS-222.  The dose was then injected 
directly into the dorsal aorta.  Dosed animals were transferred to 2 ft circular tanks (4 per 
tank) supplied with Lake Superior water (11 ± 1 ºC).  One tank of animals was sacrificed 
at 1, 3, 7, and 14 days post dosing to obtain samples of plasma, liver, kidney, and 
muscle.  Tissues from unexposed fish served as controls.  All samples were stored at 
−20 ºC for later analysis.  
2.7. Plasma binding  
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PFOA binding in trout plasma was evaluated using an ultra-filtration method 
(Centrifree YM-30 filter units; EMD Millipore, Billerica, MA).  Preliminary studies showed 
that PFOA spiked into physiological saline exhibited a high level of non-specific binding 
to the filter cartridge.  This non-specific binding was subsequently reduced to an 
acceptable level by spiking PFOA into plasma ultrafiltrate, as recommended by the 
manufacturer.  PFOA was spiked into trout plasma or plasma ultrafiltrate at 1 and 10 
g/mL (n = 5 each).  Samples (200 µL) were loaded into pre-conditioned filter units and 
centrifuged at 2000 RCF for 30 min.  Binding was then determined from the difference in 
measured concentrations of PFOA in spiked samples and sample filtrates.  
2.8. Quality controls 
2.8.1. PFOA recovery 
Preliminary experiments were conducted to measure the recovery of PFOA from 
spiked samples of plasma, urine, and trout holding water.  Samples of plasma and urine 
were spiked with 10, 100, and 1000 g/mL of non-labeled PFOA standard (n = 9 each), 
mixed by vortexing for 30 s, and allowed to equilibrate overnight.  The samples were 
then extracted and analyzed as described under analytical methods.  Recoveries from 
plasma (mean ± SD) averaged 112.3 ± 9.9, 114.4 ± 3.9, and 109.6 ± 2.2% for the 10, 
100, and 1000 g/mL samples, respectively.  An overall average recovery of 112.1% was 
subsequently used to correct measured values from toxicokinetic studies.  Recoveries 
from urine averaged 99.4 ± 8.7, 101.7 ± 5.8, and 99.6 ± 4.5% for the10, 100, and 1000 
g/mL samples, respectively, and were not used to correct measured values.  Tank water 
samples were spiked with 0.01 and 0.1 g/mL of PFOA standard (n = 5 each).  
Recoveries averaged 112.3 ± 7.7 and 101.5 ± 7.6% for the 0.01 and 0.1 g/mL samples, 
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respectively.  An overall average recovery of 106.9% was subsequently used to correct 
measured values. 
2.8.2. PFOA adsorption 
Due to their surfactant properties, PFAAs in aqueous solution tend to adsorb to 
solid phases such as glass and plastic.  Preliminary work was therefore conducted to 
evaluate the potential for PFOA to adsorb to the dorsal aortic cannula, as this could 
interfere with both i.a. dose administration and subsequent efforts to measure PFOA in 
blood.  A syringe pump (CMA/100; Harvard Apparatus, Holliston,MA) was used to infuse 
a cannula with trout plasma spiked with 25 ng/mL PFOA.  The pumping rate was set to 1 
mL/min, and the plasma was collected at 30-s intervals for 9 min.  The cannula was then 
infused with physiological saline to determine how rapidly PFOA was flushed from the 
system.  The concentration of PFOA in saline declined rapidly over time (>95% by 1 min; 
supplementary data, Appendix 1, Fig. S2-1).  Because some mixing occurs within the 
cannula when solutions are changed, it is not clear whether the small amount of PFOA 
“retained” at early time points was due to desorption of bound chemical or mixing effects.  
In any case, the i.a. dose administered to each fish was chased with 0.5 mL of clean 
saline.  The cannula was then filled with heparinized saline prior to the first blood 
sampling period to maintain its patency.  Blood sampling procedures, which include 
discarding the first 250 µL of blood and filling the cannula with heparinized saline 
between sampling times, also were designed to minimize sample-to-sample 
contamination.  Under these circumstances, binding and/or mixing effects are unlikely to 
have a discernible impact on measured PFOA concentrations. 
Additional tests were conducted for the urine catheters using urine samples 
spiked with 10 ng/mL PFOA.  Again, these tests suggested a small degree of binding 
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and/or mixing effects.  However, PFOA concentrations rapidly approached zero when 
the catheters were flushed with clean saline (data not shown). 
2.9. Analytical methods  
2.9.1. Plasma samples  
Plasma samples were extracted using an acetonitrile protein precipitation method 
(Flaherty et al., 2005; Reagen et al., 2008).  Briefly, samples (10 µL) were diluted into 
990 µL (bolus dose elimination experiments) or 490 µL (branchial uptake experiments) 
ice-cold 75% acetonitrile (ACN)/25% de-ionized (DI) water in 1.5- mL microcentrifuge 
tubes.  The tubes were vortexed for 30 s, placed on ice for 15 min, and centrifuged at 
6000 RCF for 6 min to pellet precipitated proteins.  A subsample (98 µL) of the 
supernatant was transferred to a 2-mL liquid chromatography (LC) vial with insert and 
spiked with 2 L of [13C] PFOA in 75% ACN/25% DI water as an internal standard (final 
concentration of 5 ng/mL).  These subsamples were then vortexed briefly and analyzed 
by LC/MS/MS. 
2.9.2. Water samples  
PFOA concentrations in water samples collected during the elimination studies 
were too low for direct measurement.  It was therefore necessary to extract and 
concentrate the samples using a solid phase extraction (SPE) method (Taniyasu et al., 
2005, 2008).  SPE cartridges (Oasis WAX 6 cm3, 150 mg, 30 µm) were conditioned by 
passing 4.0 mL of 0.1% ammonium hydroxide in methanol at 2 drops per sec, followed 
by 4 mL of pure methanol and finally 4.0 mL of de-ionized water.  A sample (1.0 L) was 
passed through a cartridge at the same rate, after which the cartridge was washed with 
4.0 mL of 25 mM sodium acetate buffer (fraction 1, discarded).  PFOA was eluted by 
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passing 4.0 mL of methanol through the cartridge (fraction 2), followed by 4.0 mL of 
0.1% ammonium hydroxide in methanol (fraction 3).  PFOA was found to elute entirely in 
fraction 3.  The fraction 3 eluant was diluted 3:4 with 75% ACN/25% DI water, spiked 
with internal standard to a final concentration or 5 ng/mL, and analyzed by LC/MS/MS.  
Water samples from the branchial uptake experiments were diluted 1:4 with 75% 
ACN/25% DI water and mixed by vortexing for 30 s.  Subsamples (98 µL) were then 
transferred to LC vials with inserts, spiked with 2 µL of internal standard to a final 
concentration of 5 ng/mL, and analyzed by LC/MS/MS.  
2.9.3. Urine samples 
Urine samples were diluted 1:9 with 75% ACN/25% DI water and vortexed for 30 
s.  Subsamples (98 µL) were then transferred to LC vials with inserts, spiked with 2 µL of 
internal standard to a final concentration of 5 ng/mL, and analyzed by LC/MS/MS.  
2.9.4. Tissue samples 
Samples of liver, kidney, and muscle (0.5 g) were placed in 15 mL polypropylene 
centrifuge tubes and spiked with internal standard to a final concentration of 5 ng/mL.  
Samples were homogenized (Polytron tissue homogenizer, Brinkman Instruments, 
Westbury, NY) in nine volumes of 75% ACN/25% DI water for 2 min at approximately 
15,000 rpm, and centrifuged for 20 min at 10,000 RCF to form a solid pellet.  A 
subsample (100 µL) of the supernatant was then transferred to an LC vial with insert for 
analysis by LC/MS/MS. 
2.9.5. Bile samples 
Initially, we attempted to analyze bile samples by diluting them in solvent and 
centrifuging to remove particulates.  However, this caused significant changes in the 
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retention time of PFOA, presumably due to the effects of bile acids on the column.  In 
addition, there was a loss in signal, thought to be due to accumulation of material on the 
lens and spray chamber of the MS detector.  Because of this, we used an SPE cleanup 
step similar to that used to concentrate and extract water samples from the elimination 
studies.  A subsample of the collected bile (40 µL) was diluted into 200 mL of de-ionized 
water.  This solution was then spiked with internal standard to a final concentration of 5 
ng/mL and mixed by inverting.  Samples were extracted and concentrated using the SPE 
extraction procedure described above for water samples, and analyzed by LC/MS/MS. 
2.9.6. Quantitation 
Samples were analyzed on an Agilent HPLC/Triple Quadrupole 6410 tandem 
mass spectrometer (LC/MS/MS).  Chromatographic separation of PFOA was carried out 
on an Agilent Zorbax ExtendC18 column (3.5 m, 2.1 mm × 100 mm).  Mobile phase A 
was 2% ethanol, 1% methanol, 2% 250 mM ammonium acetate in methanol, 96% water, 
and 0.01% of 25% ammonium hydroxide, pH 8.2.  Mobile phase B was 2% ethanol, 2% 
water, 1% 250 mM ammonium acetate in methanol, 95% methanol, and 0.01% of 25% 
ammonium hydroxide.  The isocratic flow rate was 0.2 mL/min at 69% mobile phase B, 
and the injection volume was 10 L.  PFOA eluted at 2.7 min and was detected using an 
electrospray ionization (ESI) source operating in the negative mode.  Detection was 
based on the transition from 413 to 369 (m/z) for PFOA and 417 to 372 (m/z) for mass-
labeled PFOA internal standard.  Quantitation was carried out against a standard curve 
constructed from known quantities of standard and a known, constant quantity of mass-
labeled internal standard in 75% ACN/25% DI water.  Blank samples spiked with internal 
standard were run for solvents used in extractions, and each animal provided its own 
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pre-dosing samples for analysis of background concentrations of PFOA in plasma, urine, 
and expired water. 
2.10. Modeling and data analysis 
Plasma, urine, and expired water time-course data were analyzed by 
compartmental modeling using the SAAM-II kinetic analysis software package (The 
Epsilon Group, Charlottesville, VA; Barrett et al., 1998).  An examination of plasma data 
from preliminary elimination studies showed that there was a distinct distribution phase 
followed by a longer, log-linear elimination phase.  Based on these findings we elected 
to use a two-compartment model with elimination from the central compartment (Fig. 2-
1A).  The two elimination routes (urine and expired water) were modeled as additional 
compartments.  This allowed the model to fit the two elimination routes simultaneously.  
The models were fitted using data-relative variance, assigning a fractional standard 
deviation (FSD) of 0.1 to the plasma data, and an FSD of 0.5 to urine and expired water 
data.  Fitted values were obtained from the model for kinetic parameters for distribution 
(k1,2, k2,1; 1/h), renal elimination (k3,1; 1/h), branchial elimination (k4,1; 1/h), and the 
apparent volume of the central compartment (VC; mL/kg).  Renal (CLR; mL/h/kg) and 
branchial clearance (CLB; mL/h/kg) were calculated as the product terms VC × k3,1 and 
VC × k4,1, respectively.  Total clearance (CLT; mL/h/kg) was calculated as the sum of 
renal and branchial clearances.  Steady-state volume of distribution (VSS; mL/kg) was 
calculated as the sum of VC and the volume of the peripheral compartment (VP; mL/kg), 
calculated as (VC × k1,2)/k2,1.  Plasma data from the branchial uptake studies were 
modeled using a two-compartment model (Fig. 2-1B), with elimination from the central 
compartment represented by a single clearance constant (k3,1; mL/h/kg).  Kinetic 
parameters for transfer to and from the peripheral compartment (k1,2 and k2,1) were fixed 
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at mean values determined from previous elimination studies (model 1A).  Similarly, the 
value of k3,1 was calculated as the sum of previously determined mean values for k3,1 
and k4,1.  Using this approach, the only term fitted by the model is the clearance constant 
for chemical uptake by the central compartment (kU; L/d/kg), which operates against the 
measured PFOA concentration in inspired water (CINSP). 
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Fig. 2-1.  Compartmental models used to describe PFOA kinetics in trout following bolus 
intra-arterial injection (1A) or continuous waterborne exposure (1B).  Samples collected 
to evaluate the kinetics of PFOA over time are denoted with the symbol “S”.  The 
identities of individual rate constants (k1,2, etc.) and the means by which they were 
determined are described in the text.  Inter-compartmental rate constants are labeled 
using the naming convention employed by the SAAM-II modeling software.  Under this 
convention, a rate constant designated ka,b refers to chemical flux to compartment “a” 
from compartment “b.” 
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Fig. 2-2.  Kinetics of PFOA elimination from trout following a bolus intra-arterial injection.  Data and model simulations are shown for 
Fish 1.  Measured concentrations in plasma are shown as solid dots.  Open triangles and open squares denote the cumulative mass 
of PFOA eliminated in urine and expired water, respectively.  Lines show the optimized fit of model simulations to measured values: 
solid line – plasma, short dashes – expired water, long dashes – urine.
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3. Results 
3.1. Performance of chambered fish 
Table 2-1 provides physiological parameters for all trout used in kinetic studies 
with PFOA.  These values are similar to those reported in previous studies of chambered 
trout (Fitzsimmons et al., 2009; McKim and Goeden, 1982; McKim et al., 1994, 1999), 
suggesting the tested animals were of acceptable quality. 
Table 2-1 
Physiological performance of chambered fisha 
 
Study design 
Parameter 
Bolus dose, elimination 
studies 
Branchial uptake studies 
Weight (g) 1146 (68) 1147 (345) 
Gender 6 ♂, 2♀ 5 ♂, 3 ♀  
Ventilation volume (VVOL; mL/min) 156 (36.2) 163 (33.8) 
Oxygen consumption (VO2; mg/h/kg) 41.8 (19.3) 46.3 (21.0) 
Urine flow rate (UFR; mL/d/kg) 92.1 (28.1) not measured 
    aReported values are given as the mean (SD) for each study design 
 
3.2. Bolus dose PFOA elimination experiments 
Fig. 2-2 shows a log-scale plasma elimination curve for a representative animal 
given a bolus dose of PFOA.  Plots for the other seven animals comprising this portion of 
the study are provided as supplementary data (Appendix 1, Figs. S2-2–S2-8).  The log-
transformed plasma concentration curve demonstrates a clear distribution phase for 
PFOA, followed by an extended log-linear elimination phase.  The data for urine and 
branchial elimination represent the cumulative amount (ng) of PFOA eliminated over 
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time.  For this particular animal, the cumulative renal elimination was approximately ten-
fold higher than that for branchial elimination.  Calculated kinetic parameters for fish 
used in the elimination studies are provided in Table 2-2.  Means (±SD) determined for 
VSS and T1/2 were 523.7 (±138.2) mL/kg and 12.6 (±7.2) d, respectively.  The variance in 
fitted VSS values was small relative to the mean value (CV= 26%) while that observed for 
T1/2 was somewhat larger (CV= 51%).  The ratio of renal clearance to branchial clearance 
varied from approximately 2.8–18.1 (mean of 11.2).  Across all the animals, the average 
fraction of the overall elimination attributable to urine was 88.5%.  These experiments 
were not designed to study sex-differences in PFOA elimination by rainbow trout, and it 
is not possible to draw a statistically meaningful conclusion based on them.  An 
examination of derived kinetic parameters suggests, however, that there were no 
consistent gender-specific differences in distribution or clearance.  Thus, while the 
lowest rates of total and renal clearance were exhibited by a female fish (no. 7), 
clearance rates determined for the other female (no. 2) were similar to those calculated 
for several males.
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Table 2-2 
Kinetic parameters and tissue/plasma concentration ratios from elimination studies with chambered trout 
 
Fish 1 Fish 2 Fish 3 Fish 4 Fish 5 Fish 6 Fish 7 Fish 8 Mean (SD) 
 Sex ♂ ♀ ♂ ♂ ♂ ♂ ♀ ♂  
 Weight 1032 1179 1134 1274 1172 1120 1132 1024 1146 (68) 
 Kinetic parameters 
                
 VSS (mL/kg) 296.4 432.9 510.2 732.3 526.5 680.6 456.5 554.4 523.7 (138.2) 
 ClR (mL/h/kg) 1.1 1.26 0.91 2.25 0.59 0.68 0.39 3.6 1.35 (1.07) 
 CLB (mL/h/kg) 0.11 0.09 0.05 0.12 0.14 0.11 0.14 0.23 0.12 (0.05) 
 ClT (mL/h/kg) 1.21 1.35 0.97 2.37 0.73 0.8 0.53 3.83 1.47 (1.11) 
 T1/2 (d) 6.9 7.9 13.4 7 17.7 22 21.9 3.7 12.6 (7.2) 
 
 Tissue/plasma, urine/plasma, and bile/plasma concentration ratios at takedown  
 Liver 0.22 0.16 0.39 0.41 0.24 0.28 0.33 0.53 0.32 (0.12) 
 Kidney 0.24 0.24 0.26 0.46 0.25 0.24 0.37 0.46 0.31 (0.10) 
 Muscle 0.015 0.008 0.009 0.011 0.011 0.026 0.013 0.013 0.013 (0.006) 
 Urine 0.24 0.57 0.65 0.72 0.17 0.52 0.09 0.76 0.46 (0.24) 
 Bile 0.13 0.1 0.14 0.46 0.12 0.14 0.21 0.12 0.18 (0.12) 
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Although the methods employed in this study did not permit a kinetic evaluation 
of PFOA elimination to bile, bile produced by chambered fish tends to be retained within 
the gallbladder.  It is possible, therefore, to evaluate this route of elimination by 
measuring the volume of stored bile and resulting concentration of PFOA.  The 
bile/plasma concentration ratio for these animals averaged 0.18, which suggests that 
PFOA was not being actively secreted into bile.  The mean PFOA concentration at the 
conclusion of the exposure was 264 ng/mL, while the average volume of collected bile 
was 2.8 mL.  Multiplying gives an average total mass of 739 ng, which is substantially 
lower than the cumulative mass of chemical eliminated by renal and branchial routes 
(255.1 and 19.9 g, on average, respectively). 
3.3. Branchial uptake experiments 
Initial uptake studies were carried out at nominal aqueous concentrations of 5 
and 50 g/L PFOA.  In each case there were no measurable differences in concentration 
between inspired and expired water, and no increase in plasma PFOA concentration 
above that of background (data not shown).  Subsequent exposures were conducted at 
a nominal concentration of 500 g/L.  As before, there were no differences in PFOA 
concentration in water entering and exiting the gills.  However, measured PFOA 
concentrations in plasma were well above those of background, increasing rapidly during 
the first 24 h and then approaching an apparent steady-state value.
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Table 2-3 
Kinetic parameters and tissue/plasma concentration ratios from branchial uptake studies with chambered trout 
 
Fish 1 Fish 2 Fish 3 Fish 4 Fish 5 Fish 6 Fish 7 Fish 8 Mean (SD) 
 Sex ♀ ♂ ♂ ♂ ♀ ♂ ♀ ♂  
 Weight 1496 1295 1563 1470 968 728 844 814 1147 (345) 
 PFOA water exposure (ng/mL) 296.4 296.4 296.4 296.4 288.4 288.4 288.4 288.4  
 
Kinetic parameters 
                  
 kU (L/d/kg) 0.12 0.13 0.08 0.09 0.26 0.30 0.30 0.21 0.19 (0.09) 
 Uptake efficiency (%) 0.07 0.06 0.03 0.03 0.19 0.18 0.17 0.07 0.10 (0.07) 
 
Tissue/plasma concentration ratios at takedown  
 Liver 0.62 0.18 0.75 NS 0.16 0.34 0.30 0.20 0.36 (0.23) 
 Kidney 0.66 0.18 0.76 NS 0.59 0.35 0.61 0.24 0.48 (0.22) 
 Muscle 0.021 0.010 0.016 NS 0.076 0.012 0.014 0.012 0.023 (0.024) 
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Branchial uptake rate constants (kU; L/d/kg) were obtained by fitting model 
simulations to measured plasma concentration time-course data (Table 2-3).  Table 2-3 
also provides chemical uptake efficiency values for each animal, calculated as kU/VVOL.  
A representative plot of modeled PFOA concentrations, along with measured values, is 
shown in Fig. 2-3.  Plots for the other seven animals are provided as supplementary data 
(Appendix 1, Figs. S2-9–S2-15).  Uptake rate constants for all animals were low, ranging 
from 0.08 to 0.30 L/d/kg.  Branchial uptake efficiencies ranged from 0.03 to 0.19%, 
averaging 0.13%.  
3.4. Tissue distribution experiment  
Data from the tissue distribution study were developed as a set of tissue/plasma 
concentration ratios to investigate how rapidly the fish approached an internal steady-
state (Table 2-4).  Tissue/plasma ratios for all tissues did not change significantly after 
the first sampling time, suggesting that the majority of the distribution phase was 
complete by 24 h.  This finding is consistent with the kinetics of PFOA in plasma 
observed in elimination studies.  The tissue distribution data were not sufficient to 
calculate a full chemical mass-balance.  Nevertheless, it was possible to estimate the 
fraction of the administered dose remaining in the sampled tissues at different time 
points, assuming that each tissue comprises a fixed fraction of total body weight.  A 
fractional body weight of 2.45% was used for plasma, assuming a fractional blood 
volume of 3.5% and a hematocrit of 30% (Barron et al., 1987).  Fractional body weights 
for other tissues were taken to be 67% for muscle, 1.27% for liver, and 0.76% for kidney 
(Nichols et al., 1990).  These calculated values, which are given in Table 2-4, suggest 
that more than half of the administered dose was eliminated during the first 24 h post 
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dosing, before the chemical had a chance to achieve an internal steady-state 
distribution.
  
 
 
5
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Fig. 2-3. Kinetics of PFOA in trout plasma during a continuous waterborne exposure – Fish 1.  Measured values are shown as 
individual points.  The fitted model simulation is shown as a solid line. 
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Table 2-4 
 Kinetics of PFOA distribution to selected tissues and organs following bolus intra-arterial 
injectiona 
  Controls Day 1 Day 3 Day 7 Day 14 
 Sex 1 ♂, 3♀ 2 ♂, 2♀ 2 ♂, 1♀ 2 ♂, 2♀ 1 ♂, 3♀ 
 Weight (g) 214.5 (8.7) 271.8 (3.8) 278.7 (33.3) 295.8 (36.6) 242.0 (28.7) 
 [PFOA]plasma 
(ng/mL) 
BQb 4762 (913) 2511 (791) 1252 (361) 346 (179) 
 
Tissue/plasma ratios 
        
 Liver BQb 0.145 (0.036) 0.156 (0.023) 0.161 (0.019) 0.193 (0.058) 
 Kidney BQb 0.121 (0.041) 0.154 (0.041) 0.137 (0.014) 0.177 (0.068) 
 Muscle BQb 0.011 (0.004) 0.011 (0.001) 0.010 (0.001) 0.015 (0.007) 
 Bile BQb 0.308 (0.039) 0.552 (0.204) 0.384 (0.052) 0.557 (0.249) 
 
Mass-balance estimates - % of initial dose remaining 
  
 Plasma BQb 11.67 (2.24) 6.15 (1.94) 3.07 (0.88) 0.85 (0.44) 
 Muscle BQb 3.49  (0.77) 1.90 (0.45) 0.87 (0.27) 0.32 (0.12) 
 Liver BQb 0.87  (0.26) 0.48 (0.08) 0.25 (0.05) 0.08 (0.02) 
 Kidney BQb 0.42  (0.08) 0.29 (0.08) 0.13 (0.03) 0.05 (0.04) 
a.Data presented as mean (SD), n=4. 
b.BQ = Concentration too low to quantitatively measure   
 
3.5. Plasma binding 
The mean (±SD) recovery of PFOA from spiked samples of plasma ultrafiltrate 
was 71.9 ± 7.4%.  In contrast, PFOA concentrations in filtrates of whole plasma were all 
below the limit of quantitation (5 ng/mL).  It was not possible, therefore, to calculate 
plasma binding of PFOA with any certainty.  However, it appears that this binding 
exceeded 99%. 
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4. Discussion 
The PFAAs represent an important class of environmental contaminants.  
Although individual members of this chemical class have been banned or are voluntarily 
being phased out of production, new, generally shorter chain compounds have been 
developed as replacements (Lau, 2009; Lau et al., 2007).  It is critical, therefore, to 
develop an improved understanding of their behavior in the environment, including their 
uptake and elimination by fish.  The results of the present study indicate that renal 
clearance is the dominant route of PFOA elimination in rainbow trout.  Based on 
modeled values, the ratio of CLR to CLB varied somewhat among animals (ranging from 
2.8 to 18.1).  Some of this variability may have been due to differences in the gender of 
tested animals as well as their state of sexual maturity.  Nevertheless, CLR as a fraction 
of CLT exceeded 73% in all fish and averaged 88.5%.  To our knowledge, this is the first 
direct demonstration that renal clearance contributes substantially to elimination of a 
PFAA by fish.  
Until now, the only detailed studies of the kinetics of PFOA in rainbow trout were 
those conducted by Martin et al. (2003a, 2003b).  Our model-fitted PFOA half-life from 
the elimination experiments averaged 12.6 d, which compares to 5.2 d reported by 
Martin et al. (2003a; carcass value).  While this is slightly more than a twofold difference, 
it is important to note that Martin et al. (2003a) obtained fitted uptake and elimination 
values for animals weighing approximately 7 g.  To the degree that processes (e.g., gill 
ventilation, urine production) responsible for PFOA elimination scale to a fractional 
exponent of body weight, the slower elimination rate observed in the present study may 
reflect the large size of fish (averaging over 1 kg) required for chambered experiments.  
De Silva et al. (2009) reported a PFOA half-life of 5.6 d in trout weighing 36 g.  This 
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result agrees well with that obtained by Martin et al. (2003a) and is subject to the same 
allometric considerations when compared to the present effort.  Lee and Schultz (2010) 
used an oral dosing approach to study the uptake and elimination of PFOA in fathead 
minnows of both genders.  The whole-body half-life in male minnows was approximately 
68.5 h, while that determined for females was 6.3 h.  This difference was greatly reduced 
by either pretreatment of females with 17-trenbolone or males with estradiol.  Although 
the present study was not designed to test sex-based differences in elimination, it is 
clear that there were no consistent differences on the same order as those reported in 
fathead minnows. 
While it was not possible to characterize the kinetics of PFOA elimination in bile, 
the fact that bile accumulated in the gallbladder during the course of each experiment 
allowed for a quantitative recovery of compound eliminated by this route.  The resulting 
mass balance estimate for PFOA elimination in bile was far smaller than values 
calculated for renal or branchial elimination.  This observation is consistent with an 
earlier finding that PFOA concentrations in bile were similar to those in plasma after a 
28-d aqueous exposure (Martin et al., 2003a).  Because the oral bioavailability of PFOA 
is relatively high (60%; Martin et al., 2003b), it is also likely that PFOA eliminated to 
feces would be reabsorbed by the animal.  Taken together, these findings suggest that 
bile is an unimportant route of elimination for this compound. 
Chambered trout were also used to assess branchial uptake of PFOA.  Slow 
uptake across the gills made it infeasible to directly evaluate this process using 
measured chemical concentrations in inspired and expired water.  We therefore modeled 
uptake using measured plasma time-course data and an average concentration in water.  
The average model-fitted value for kU was 0.19 L/d/kg.  Using individual uptake terms 
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from the models and measured ventilation volumes for each fish, we calculated a mean 
uptake efficiency of 0.1%.  
For comparison, Martin et al. (2003a) reported a fitted uptake clearance of 0.53 
L/d/kg.  In order to relate this value to the present study, however, it is necessary to 
account for the effect of fish size on ventilation volume.  Arnot and Gobas (2004) used 
data provided by Thurston and Gehrke (1990) to develop an allometric relationship for 
oxygen consumption in fish (VOX; mg O2/d): VOX = 980WB0.65, where WB is the fish’s 
weight in kg.  To develop a similar expression for QV in trout we adopted the same 
allometric exponent and applied this to the measured QV for a 1 kg animal (10.6 L/h; 
Nichols et al., 1990): QV = 10.6WB0.65.  Using this relationship, the predicted QV for a 7 g 
trout is approximately 60.2 L/h/kg.  Dividing this value into the uptake clearance given by 
Martin et al. (2003a) yields an average uptake efficiency of 0.037%, which is within the 
range of values determined in the present study.  These calculations provide only a 
rough basis for comparing the present study to that of Martin et al. (2003a), and other 
factors may have contributed to the modest difference in study results including 
differences in fish strain and stage of development.  Nevertheless, it is clear from both 
efforts that the efficiency of PFOA uptake directly from water is very low. 
Tissue data from all three sets of experiments showed that PFOA has a high 
affinity for plasma relative to that for other tissues.  This finding is consistent with 
previous observations in both fish and mammals, and provides a likely explanation for 
the low estimated VSS (0.52 L/kg) determined in bolus injection studies.  A detailed 
comparison of our tissue data to that provided by Martin et al. (2003a) is complicated by 
the fact that this latter study reports measured concentrations graphically as log-scaled 
values (Fig. 2 of the cited paper).  However, a general comparison is still instructive.  As 
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in this earlier study, the concentration of PFOA in tissues followed the general pattern: 
plasma > liver > kidney > muscle.  Tissue/plasma concentration ratios at equilibrium 
(based on means for chambered fish as well as means for days 3, 7, and 14 of the 
tissue distribution study) ranged from 0.16 to 0.36 for liver, 0.16–0.48 for kidney, and 
0.010–0.023 for muscle.  Using data reported by Martin et al. (2003a), similar ratios may 
be calculated for liver (approximately 0.5) and kidney (approximately 0.15).  PFOA 
concentrations in muscle reported by Martin et al. (2003a) suggest a muscle/plasma 
ratio of approximately 0.1.  This value is 5–10 times higher than that determined in the 
present study.  Nevertheless, both studies indicate that PFOA has little affinity for 
muscle tissue relative to that for plasma. 
As noted previously, existing models for accumulation of PFAAs in fish either do 
not explicitly account for renal elimination (Armitage et al., 2013) or have been 
parameterized using data from mammals (Ng and Hungerbühler, 2013).  The present 
work confirms the importance of renal elimination for one member of this chemical class, 
and provides an initial dataset that can be used to model this process.  Although 
additional work is needed to determine whether other PFAAs are eliminated by fish in 
the same manner, the results of this effort suggest that differences in renal handling of 
individual PFAAs may substantially determine their rate of elimination by fish, and by 
extension their relative propensity to accumulate. 
Finally, we note with interest the possibility that membrane transporters play an 
important role in renal elimination of PFAAs by fish, as is understood to occur in 
mammals.  Renal elimination is the primary determinant of differences in the overall rate 
of elimination among different species of mammals, and between sexes of the same 
species (Andersen et al., 2006; Butenhoff et al., 2004b; Han et al., 2012).  Additional 
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work has shown that these differences are due to variable expression of, and complex 
interactions between, specific renal transporters (Kudo et al., 2002; Nakagawa et al., 
2009; Weaver et al., 2010).  The sex-based difference in PFOA elimination observed in 
at least one fish species (fathead minnows; Lee and Schultz, 2010), along with the 
observed predominance of urine as a route of PFOA elimination in trout, suggest that 
similar processes are operating in fish. 
Gene expression studies indicate that fish possess a diverse array of membrane 
transport proteins including ATP binding cassette (ABC)transporters (Fischer et al., 
2011; Loncar et al., 2010) and solute carriers (SLC; Verri et al., 2012), the latter of which 
include organic anion transporters (Oats) and organic anion transporting polypeptides 
(Oatps; Popovic et al., 2010).  Most transporters probably evolved to transport 
endogenous substrates (e.g., bile salts, cyclic nucleotides, hormones) or naturally-
derived toxins.  However, functional studies suggest that many are capable of 
transporting xenobiotic substances (Aslamkhan et al., 2006; Bard, 2000; Doi et al., 2001; 
Fischer et al., 2011, 2013; Miller et al., 1998; Sturm et al., 2001; Sturm and Segner, 
2005; Zaja et al., 2008, 2011).  In this regard, ABC transporters have been given special 
attention because of their ability to transport compounds against their electrochemical 
gradient.  By comparison, functional studies of Oats and Oatps from fish are fewer in 
number (Boaru et al., 2006; Meier-Abt et al., 2007; Wolff et al., 1997).  
With respect to renal transporters, a substantial literature indicates that fish 
kidneys secrete both “classical” substrates for Oats (e.g., p-aminohippurate) as well as 
some anionic environmental contaminants (e.g., 2,4-dichlorophenoxyacetic acid; 
Pritchard and James, 1979).  The role of the kidney in secreting products of Phase I and 
II biotransformation also is well-established (McKim et al., 1999; Pritchard and Bend, 
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1991, 1984).  To date, however, there have been few studies showing that membrane 
transporters, renal or otherwise, limit the accumulation of an important environmental 
contaminant in fish, absent biotransformation. 
Although the present study does not prove that transporters are responsible for 
renal clearance of PFOA by trout, a close examination of the data provides indirect 
evidence supporting this conclusion.  Previously, McKim et al. (1999) determined the 
glomerular filtration rate (GFR) in chambered trout to be 6.1 mL/h/kg.  The average urine 
flow rate (UFR) for the same animals was 4.3 mL/h/kg.  In the present study, the 
measured UFR, averaged across all animals (mean ± SD), was 3.8 ± 1.1 mL/h/kg.  We 
may assume, therefore, that the GFR determined by McKim et al. (1999) reasonably 
approximates that of fish exposed to PFOA.  Binding studies conducted as part of the 
current study indicated that PFOA is nearly 100% bound in trout plasma.  Based on this 
information, the renal clearance that would have been predicted to occur due to 
glomerular filtration is negligible (0.1 mL/h/kg).  Instead, the average CLR was 1.35 
mL/h/kg, which is 22% of the estimated GFR. 
Averaged across all fish in Table 2-2, the total PFOA concentration in urine at 
test termination was 46% of that in plasma.  We did not measure PFOA binding in urine 
so it is unclear whether free concentrations in urine exceeded those in plasma.  
However, freshwater fish are known to produce highly dilute urine (Hickman and Trump, 
1969), so it is possible that much of the PFOA in urine was freely dissolved.  
Characterizing the free concentrations of PFOA in urine and plasma is important 
because this may indicate whether the mechanisms responsible for renal clearance 
require energy to overcome an electrochemical gradient.  Additional experiments 
utilizing chemical inhibitors of specific Oats may confirm whether renal transporters 
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contribute to the elimination of PFOA by trout, while studies conducted at different 
dosing levels would indicate whether these systems saturate at toxicologically relevant 
concentrations.  The chambered trout model provides an excellent system for exploring 
these questions. 
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Chapter 3: Toxicokinetics of perfluorooctane sulfonate in rainbow trout 
(Oncorhynchus mykiss) 
Daniel M. Consoer, Alex D. Hoffman, Patrick N. Fitzsimmons, Patricia A. Kosian, and 
John W. Nichols. 
Published in Environmental Toxicology and Chemistry, March, 2016. Volume 35(3), p 
717-27. 
Abstract 
Rainbow trout (Oncorhynchus mykiss) confined to respirometer-metabolism 
chambers were dosed with perfluorooctane sulfonate (PFOS) by intra-arterial injection 
and sampled to obtain concentration time-course data for plasma and either urine or 
expired water.  The data were then analyzed using a 2-compartment clearance-volume 
model.  Renal and branchial clearance rates (mL/d/kg) determined for all experiments 
averaged 19% and 81% of total clearance, respectively.  Expressed as mean values for 
all experiments, the steady-state volume of distribution was 277 mL/kg and the terminal 
half-life was 86.8 d.  Additional animals were exposed to PFOS in water, resulting in an 
average calculated branchial uptake efficiency of 0.36%.  The renal clearance rate 
determined in the present study is approximately 75 times lower than that determined in 
earlier studies with perfluorooctanoate (PFOA).  Previously, it was suggested that PFOA 
is a substrate for membrane transporters in the trout kidney.  The present study 
suggests that glomerular filtration may be sufficient to explain the observed renal 
clearance rate for PFOS, although a role for membrane transporters cannot be ruled out.  
These findings demonstrate that models developed to predict the bioaccumulation of 
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perfluoroalkyl acids by fish must account for differences in renal clearance of individual 
compounds. 
 
Introduction 
The perfluoroalkyl acids (PFAAs), including the perfluorosulfonates (PFSAs) and 
perfluorocarboxylates (PFCAs), are widely used as lubricants, surfactants, stain-
resistant coatings, fire-fighting foams, and photographic developers.  Initial concerns 
regarding the PFAAs as a class of environmental contaminants date to a 2001 article by 
Geisy and Kannan (2001) on the global distribution of perfluorooctane sulfonate (PFOS) 
in wildlife.  This finding prompted numerous studies which have demonstrated the 
accumulation of PFOS and other PFAAs in aquatic and terrestrial animals, the 
environment, and humans.  Subsequent work has shown that bioaccumulation and the 
potential for biomagnification of PFAAs in fish depends on the properties of individual 
compounds (Kannan et al., 2005; Furdui et al., 2007; Conder et al., 2008; Ishibashi et 
al., 2008; Ahrens et al., 2014).  Generally, bioaccumulation is greater for the PFSAs than 
the PFCAs and increases with the length of the perfluorocarbon chain.  The production 
and use of PFOS and its precursors have been restricted under the terms of the 
Stockholm Convention on Persistent Organic Pollutants (i.e., as an Annex B substance), 
and other PFAAs are being phased out voluntarily (Buck et al., 2011).  Nevertheless, 
modified and shorter-chain members of this chemical class continue to be produced in 
large quantities.  It is of interest, therefore, to understand how PFAAs behave in the 
environment and to develop predictive models that describe this behavior. 
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Mechanistic models used to predict bioaccumulation of neutral organic chemicals 
in fish generally assume that uptake and elimination occur by passive diffusion and that 
chemicals partition nonspecifically to tissue lipids in accordance with their relative 
hydrophobicity, typically represented by the octanol– water partition coefficient (KOW).  
Because of their surfactant properties, it is difficult to accurately measure KOW values for 
PFAAs.  Moreover, these compounds are >99.9% ionized at physiological pH values.  
Research with mammals also suggests that PFAAs do not partition to tissue lipids but 
instead bind to specific proteins including serum albumin in the blood (Han et al., 2003; 
Chen and Guo, 2009; Bischel et al., 2011) and fatty-acid binding proteins in liver 
(Luebker et al., 2002).  The determinants of PFAA distribution in fish are less well 
known; however, observed patterns of distribution are qualitatively consistent with those 
seen in mammals (Hoff et al., 2003; Martin et al., 2003a; Shi et al., 2012; Goeritz et al., 
2013). 
Recognizing the limitations of existing approaches, Ng and Hungerbühler (2013) 
developed a model for PFAA accumulation in fish that accounts for protein binding 
interactions.  This model describes the animal as a set of 4 tissues, each of which is 
comprised of tissue and interstitial fluid compartments.  Characteristic binding 
relationships were used to determine bound and free fractions in each compartment, as 
well as in blood.  This model also accounts for possible elimination of PFAAs to urine.  
Lacking measured information for fish, however, model parameters that describe renal 
elimination were obtained from studies with rats.  Modeled simulations accurately 
described observed patterns of accumulation in blood and tissues.  Generally, however, 
the model tended to underestimate reported whole-body bioconcentration factors for 
PFAAs in fish. 
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In a previous effort, we used large trout confined to respirometer-metabolism 
chambers to study the kinetics of PFOA uptake and elimination (Consoer et al., 2014).  
When PFOA was given to fish as a bolus intra-arterial dose, approximately 90% was 
eliminated to urine.  The average renal clearance was determined to be approximately 
one-fourth the reported glomerular filtration rate (GFR) for similarly prepared animals.  
However, additional experiments showed that PFOA in trout plasma is nearly 100% 
bound.  Taken together, these observations suggest that renal clearance of PFOA in 
trout is mediated, at least in part, by membrane transporters and that these transporters 
are capable of operating against an electrochemical gradient.  The purpose of the 
present study was to use chambered trout to investigate the uptake and elimination of 
PFOS.  Because PFOS has been tested extensively to determine its toxicity to fish, 
information relating to its uptake and accumulation has value in its own right.  Our larger 
goal, however, was to support the development of mechanistic models for 
bioaccumulation of PFAAs in fish.  The results of the present study clearly demonstrate 
the critical importance of renal elimination as a determinant of this behavior and suggest 
that differences in active secretion and/or reabsorption within the kidney are responsible 
for observed differences in bioaccumulation of individual compounds. 
Materials and methods 
Chemicals 
Perfluorooctane sulfonate (>98% pure) was purchased from Sigma-Aldrich.  Both 
PFOS and mass-labeled [13C] PFOS standards were purchased from Wellington 
Laboratories.  Amersham Radiochemicals supplied the [14C] polyethylene glycol (PEG; 
50 mCi/mL in ethanol), and the Ultima Gold scintillation cocktail was obtained from 
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Packard Instruments.  High-performance liquid chromatography (HPLC)–grade 
acetonitrile, methanol, and glacial acetic acid were purchased from Fisher Scientific.  
Test organism source, care, and handling 
Rainbow trout (Oncorhynchus mykiss) weighing approximately 100 g were 
obtained from the US Geological Survey’s Upper Midwest Environmental Sciences 
Center in La Crosse, Wisconsin, and grown to the desired size for each experiment.  
The fish were fed a commercial trout chow (Silver Cup; Nelson and Sons) and 
maintained on a 16:8-h light:dark cycle at 11 ± 1ºC.  Water used for fish holding was 
obtained directly from Lake Superior (single pass, sand-filtered, and ultraviolet treated) 
and had the following characteristics: alkalinity 41 mg/L to 44 mg/L as CaCO3, pH 7.6 to 
7.8, total ammonia <1 mg/L, dissolved O2 85% to 100% of saturation.  All animals were 
fasted for 24 h prior to use. 
Surgical preparation of animals 
Elimination and branchial uptake studies were performed using trout confined to 
respirometer-metabolism chambers (McKim and Goeden, 1982).  Fish weighing 700 g to 
1500 g were surgically prepared as described (Consoer et al., 2014).  Briefly, fish were 
placed under continuous anesthesia with tricaine methane sulfonate (MS-222; Finquel; 
Argent Laboratories) and fitted with a dorsal aortic cannula (Intramedic PE 50; Becton, 
Dickinson).  Animals used for the renal elimination studies were also fitted with a urinary 
catheter (Intramedic PE 90).  A latex membrane sewn to the fish’s mouth allowed 
separate collection of inspired and expired water.  A second membrane just posterior to 
the pectoral fins prevented further dilution of expired water.  Fish were allowed 24 h to 
recover after surgery before starting an experiment.  Water temperature (Celsius), 
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ventilation volume (VVOL; L/d/kg), and O2 consumption (VO2; mg/d/kg) were monitored 
continuously using an automated data collection system and customized software 
Carlson et al., 1989).  This information was then evaluated to assess the viability and 
representativeness of each preparation and to generate average values for the 
experimental time period.  
Elimination studies 
Six fish of mixed sex (3 male, 3 female) were given a bolus intra-arterial injection 
of PFOS to study the kinetics of renal elimination.  An additional 6 animals (1 male, 5 
female) were then dosed in the same manner to study the kinetics of branchial 
elimination.  Each fish was given a nominal dose of 1.0 mg/kg, dissolved in trout plasma 
(1 mL/kg injection volume).  Blood (100 µL) was sampled periodically for 72 h to 
evaluate the kinetics of PFOS in plasma.  Urine (50–100 µL) or expired water (1 L) was 
then sampled in conjunction with blood to characterize elimination by each route.  All 
samples were collected and processed as described (Consoer et al., 2014).  
For the renal elimination studies, the volume of urine produced between 
sampling times was recorded to calculate the urine flow rate for each time period as well 
as an average urine flow rate for the entire experiment.  Two of these animals were 
injected with [14C] PEG to measure GFR.  The methods used to perform these 
measurements are described in detail elsewhere (McKim et al., 1999).  Briefly, fish were 
given a 300-µL injection of [14C] PEG (1.5 μCi in 90% physiological saline/10% ethanol) 
just after dosing with PFOS.  Blood (200 µL) and urine (200 µL) samples were then 
collected for determination of GFR at 8 h, 16 h, 32 h, and 72 h after [14C] PEG injection 
using the relationship 
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GFR[14C] PEG (mL/min/kg) = (urine DPM)(urine flow rate) / plasma DPM                      (1) 
where urine and plasma DPM refer to disintegrations/min/mL of sample and urine flow 
rate is in mL/min/kg.  Sample counting was performed for 20 min using a scintillation 
counter (Beckman Coulter). 
Fish were euthanized after the final sampling period with an overdose of MS-222.  
Samples of kidney, liver, muscle, and bile (branchial elimination studies only) were 
collected and stored at –20 ºC for later analysis.  Muscle was sampled from above the 
lateral line, anterior to the dorsal fin.  The liver, kidney, and bile were collected in their 
entirety. 
Branchial uptake studies 
Six trout of mixed sex (1 male, 5 female) were exposed to PFOS in water for 72 
h.  A stock solution was prepared by dissolving PFOS in deionized water (Milli-Q; EMD 
Millipore).  This solution was metered into a mixing cell and diluted with Lake Superior 
water.  The dilute solution was then supplied to each chambered animal in excess of its 
respiratory requirement (440 mL/min).  A preliminary uptake study was carried out at a 
nominal aqueous concentration of 0.5 ng/mL.  Under these conditions, there were no 
measurable differences in concentration between inspired and expired water, and the 
plasma PFOS concentration did not increase above that of background (data not 
shown).  All subsequent exposures were conducted at a nominal concentration of 5 
ng/mL.  Blood (100 µL), inspired water (1 L), and expired water (1 L) were sampled at 2 
h, 4 h, 8 h, 24 h, 36 h, 48 h, 54 h, and 72 h.  These samples were then processed in the 
same manner as samples obtained from PFOS elimination studies.  Samples of liver, 
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kidney, muscle, and bile were again collected attest termination and stored at –20 ºC for 
later analysis. 
Tissue distribution studies 
Twenty trout of mixed sex, weighing 150 g to 250 g each, were used to study the 
distribution time course of PFOS in liver, kidney, muscle, and plasma.  Fish were divided 
into 5 groups of 4 animals each (4 dosed and 1 control group).  The control group was 
processed immediately, and the resulting samples were stored at –20 ºC for later 
analysis.  The remaining animals were given a bolus intra-arterial injection of PFOS 
dissolved in trout plasma at a nominal dose of 1 mg/kg and placed in 2-foot circular 
tanks supplied with Lake Superior water (4 fish/tank).  One tank of animals was 
euthanized at 1 d, 3 d, 7 d, and 14 d post dosing.  All tissue samples were stored at –20 
ºC for later analysis.  
Plasma binding 
Binding of PFOS in trout plasma was evaluated using an ultrafiltration method 
(Centrifree UM-30 filter units; EMD Millipore).  Nonspecific binding to the filter cartridge 
was reduced to an acceptable level by spiking PFOS into plasma ultrafiltrate, as 
recommended by the manufacturer.  Samples of trout plasma or plasma ultrafiltrate (200 
µL) spiked with 10 µg/mL, 100 µg/mL, or 1000 µg/mL PFOS (n = 3 each) were 
centrifuged at 2000 g for 30 min.  Binding was then determined from the difference in 
measured concentrations of PFOS in spiked samples and sample filtrates. 
Quality controls 
Preliminary experiments were conducted to measure the recovery of PFOS from 
samples of plasma, urine, and Lake Superior water.  Plasma samples from unexposed 
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fish were spiked with 10 µg/mL, 50 µg/mL, and 100 µg/mL PFOS (n = 3 each), mixed by 
vortexing for 30 s and allowed to equilibrate overnight.  These samples were then 
extracted and analyzed as described below.  Recovery from plasma (mean ± standard 
deviation [SD]) averaged 93.0 ± 1.3%, 107.5 ± 12.3%, and 109.5 ± 6.5% for the 10 
µg/mL, 50 µg/mL, and 100 µg/mL samples, respectively.  An overall recovery of 103.0% 
was subsequently used to correct measured values from the kinetic studies.  Blank urine 
samples from unexposed animals were spiked with 5 µg/mL, 10 µg/mL, and 50 µg/mL 
PFOS (n = 3 each).  Recoveries averaged 92.9 ± 11.9%, 80.4 ± 3.3%, and 79.0 ± 2.5%, 
respectively.  Overall recovery from urine averaged 84.1%, and results from toxicokinetic 
studies were corrected to this value.  Tank water samples were spiked with PFOS at 
concentrations of 0.05 µg/mL, 0.5 µg/mL, and 5 µg/mL (n= 3 each).  Recoveries 
averaged 103.4 ± 16.7%, 96.9 ± 8.0%, and 107.7 ± 5.1%, respectively.  The overall 
recovery from water averaged 102.6% and was used to correct measured 
concentrations in both elimination (i.e., expired water samples) and waterborne (inspired 
water and expired water) dosing studies. 
Using methods developed for PFOA (Consoer et al., 2014) additional 
experiments were conducted to evaluate the potential for PFOS to adsorb to the blood 
cannulae and urine catheters used to dose animals and obtain samples of plasma and 
urine.  Briefly, spiked samples of plasma and urine were pumped through the 
appropriate tubing material (Intramedic PE 50 or PE 90, cut to length) at 1 mL/min for 9 
min.  Each tube was then flushed with physiological saline to determine how rapidly 
PFOS was lost from the system.  As with PFOA, these experiments suggested a small 
degree of adsorption and/or mixing effects.  However, measured concentrations of 
PFOS rapidly approached 0 when the cannula or catheter was flushed with clean saline.  
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Based on these findings, it is highly unlikely that adsorption of PFOS to blood cannulae 
or urine catheters had any impact on the present study results. 
Sample preparation and analysis 
Samples of plasma, water, urine, and tissues were processed using methods 
developed for analysis of PFOA (Consoer et al., 2014).  Briefly, plasma samples were 
extracted using an acetonitrile protein precipitation method (Flaherty et al., 2005; 
Reagen et al., 2008).  A subsample (98 µL) of the extract in 75% acetonitrile/25% 
deionized water was then transferred to a 2-mL liquid chromatography (LC) vial with 
insert and spiked with 2 µL of [13C] PFOS in 75% acetonitrile/25% deionized water as an 
internal standard (final concentration 5 ng/mL).  
Water samples from branchial elimination studies were extracted and 
concentrated using a solid-phase extraction (SPE) method (Taniyasu et al., 2005; 
Taniyasu et al., 2008).  Each sample was passed through a conditioned SPE cartridge 
(Oasis WAX 6 cm3, 150 mg, 30mM; Waters) at 2 drops/s.  The cartridge was then 
washed with 4.0 mL of 25 mM sodium acetate buffer (fraction 1, discarded).  The PFOS 
was eluted by passing 4.0 mL of methanol through the cartridge (fraction 2), followed by 
4.0 mL of 0.1% ammonium hydroxide in methanol (fraction 3).  As with PFOA, PFOS 
was found to elute entirely in fraction 3.  The fraction 3 eluant was then diluted 3:4 with 
75% acetonitrile/25% deionized water.  Water samples from the branchial uptake 
experiments were diluted 1:4 with 75% acetonitrile/25% deionized water.  Urine samples 
were diluted 1:9 with 75% acetonitrile/25% deionized water.  Subsamples (98 µL) 
derived from the processing of water and urine samples were transferred to LC vials with 
inserts and spiked with 2 µL of internal standard to a final concentration of 5 ng/mL.  
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Samples of liver, kidney, and muscle (~0.5 g) were spiked with internal standard 
to a final concentration of 5 ng/mL.  The samples were homogenized (Polytron tissue 
homogenizer; Brinkman Instruments) in 9 volumes of 75% acetonitrile/25% deionized 
water for 2 min at approximately 15 000 rpm and centrifuged for 20 min at 10 000xg to 
form a solid pellet.  A subsample (100 µL) of the supernatant was then transferred to an 
LC vial with insert.  Bile samples (40 µL) were diluted into 200 mL of deionized water.  
This solution was spiked with internal standard to a final concentration of 5 ng/mL and 
processed using the same SPE procedure described for water samples. 
Quantitation 
Samples were analyzed on a HPLC–Triple Quadrupole 6410 tandem mass 
spectrometer (Agilent Technologies).  Chromatographic separation was carried out on 
an Agilent Zorbax Extend-C18 column (3.5 µ, 2.1 x 100 mm).  Mobile phase A was 2% 
ethanol, 1% methanol, 2% 250 mM ammonium acetate in methanol, 96% water, and 
0.01% of 25% ammonium hydroxide, pH 8.2.  Mobile phase B was 2% ethanol, 2% 
water, 1% 250 mM ammonium acetate in methanol, 95% methanol, and 0.01% of 25% 
ammonium hydroxide.  The isocratic flow rate was 0.2 mL/min at 69% mobile phase B, 
and the injection volume was 10 µL.  The PFOS eluted at 4.1 min and was detected 
using tandem mass spectrometry as a transition from 499 m/z to 80 m/z for PFOS and 
503 m/z to 84 m/z for mass labeled PFOS internal standard.  Transitions from 499 m/z to 
99 m/z and from 503 m/z to 103 m/z were used as qualifier transitions.  Bile samples 
were quantitated on the basis of the 499 m/z to 99 m/z transition because of high 
background rates of taurdeoxycholate, a bile acid that shares the 499 m/z to 80 m/z 
transition.  Quantitation was carried out against a standard curve constructed from 
known quantities of standard and a known, constant quantity of mass-labeled internal 
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standard in 75% acetonitrile/25% deionized water.  Blank samples spiked with internal 
standard were run for solvents used in extractions, and each animal provided its own 
predosing samples for analysis of background concentrations of PFOS in plasma, urine, 
and expired water.  
Modeling and data analysis 
Data obtained from the elimination experiments were analyzed by compartmental 
modeling using the SAAM II kinetic analysis software package (Epsilon Group; Barrett et 
al., 1998).  In all cases, the kinetics of PFOS elimination from plasma exhibited a distinct 
distribution phase followed by a longer, log-linear elimination phase.  We therefore 
modeled these data sets using a 2-compartment model with elimination from the central 
compartment (Figure 3-1A).  The models were fitted by nonlinear regression, applying a 
data-relative variance model.  Variance was modeled by assigning a fractional SD of 0.1 
(equivalent to a SD of 10% of the measured value) to the plasma data and a fractional 
SD of 0.5 to the urine or expired water data.  Fitted values were obtained from the model 
for kinetic parameters that describe PFOS distribution (k1,2, k2,1; 1/d), renal or branchial 
elimination (k3,1; 1/d), and the apparent volume of the central compartment (VC; mL/kg).  
Initially, the renal elimination data sets were modeled by fitting a second “other” 
elimination term (k4,1; 1/d), as described below.  Renal clearance (CLR; mL/d/kg) and 
branchial clearance (CLB; mL/d/kg) were calculated as the product of VC and k3,1 for 
each set of experiments.  The steady state volume of distribution (VSS; mL/kg) was 
calculated as the sum of VC and the volume of the peripheral compartment (mL/kg), 
calculated as (VC x k1,2)/k2,1.  Assuming that very little PFOS would be eliminated in bile, 
this potential elimination route was ignored in the model.  Measured PFOS 
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concentrations in bile determined in the branchial elimination studies provided support 
for this assumption (see below, PFOS elimination to bile).
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Figure 3-1.  Compartmental models used to describe renal and branchial elimination of 
perfluorooctane sulfonate (PFOS) following bolus intra-arterial injection (A), as well as 
PFOS uptake (B) in continuous waterborne exposures.  Samples collected to evaluate 
the kinetics of PFOS over time are denoted with the symbol “S”.  The identities of 
individual rate constants (k1,2, etc.) and the means by which they were determined are 
described in the text.  Inter-compartmental rate constants are labeled using the naming 
convention employed by the SAAM-II modeling software.  Using this convention, a rate 
constant designated ka,b refers to chemical flux to compartment “a” from compartment 
“b”.
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Previously, we found that trout eliminate PFOA primarily via the urine (Consoer 
et al., 2014).  Initially, therefore, we investigated PFOS elimination by the same route.  
Renal elimination was characterized by modeling to measured concentrations of PFOS 
in urine.  An “other” elimination term (k4,1), operating against the central compartment, 
was then included as a means of accounting for nonrenal elimination.  These fitted 
models provided an excellent description of measured data but suggested that renal 
clearance was substantially lower than total clearance.  Additional studies were therefore 
conducted to characterize branchial elimination of PFOS.  In this second effort, the 
“other” elimination rate constant, k4,1, was set equal to the mean of fitted k3,1 values for 
renal elimination, obtained from the initial renal models.  To obtain a final set of 
consistent models, the renal elimination experiments were modeled a second time, 
replacing the “other” elimination rate constant k4,1 with the mean of fitted k3,1 values for 
branchial elimination, obtained from the branchial elimination models.  For both the renal 
and branchial elimination models, total clearance (CLT; mL/h/kg) was calculated as VC x 
(k3,1 + k4,1).  The terminal elimination half-life (T1/2; d), which is the time required for the 
plasma concentration to decrease by one-half during the log-linear elimination phase, 
was then calculated for each fish as 0.693/β, where (Toutain and Bousquet-Melou, 
2004) 
𝛽 =
(𝑘2,1+𝑘1,2+𝑘3,1+𝑘4,1)−𝑟
2
                                                                                (2) 
and 
𝑟 = √(𝑘2,1 + 𝑘1,2 + 𝑘3,1 + 𝑘4,1)
2
− (4 𝑥 (𝑘3,1 + 𝑘3,1) 𝑥 𝑘1,2)
2
                (3) 
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Plasma data from the branchial uptake studies were modeled using a 2-
compartment description (Figure 3-1B), with elimination from the central compartment 
represented by a single rate constant (k3,1; mL/h/kg).  Kinetic parameters for transfer to 
and from the peripheral compartment (k1,2 and k2,1) were fixed at mean values 
determined from the renal and branchial elimination studies (i.e., values averaged 
across the entire set of 12 fitted models).  The value of k3,1 was calculated as the sum of 
previously determined mean values for k3,1 and k4,1, again averaged across all 12 fish 
used in the elimination studies.  Using this approach, the only term fitted by the branchial 
uptake model is the clearance constant for chemical uptake by the central compartment 
(kU; L/d/kg), which operates against the measured PFOS concentration in inspired water 
(ng/mL). 
The quality of model fit was characterized by calculating Akaike information 
criterion (AIC) and Bayesian information criterion (BIC) values.  The SAAM-II files 
containing compartmental model schematics, example data, and model parameters are 
available on request from the corresponding author.  
Results 
Performance of chambered fish 
Table 3-1 provides physiological parameters for all chambered trout used in 
kinetic studies with PFOS.  These values are similar to those reported in previous 
studies (Consoer et al., 2014; McKim et al., 1982; McKim et al., 1999) suggesting that 
the tested animals were of acceptable quality.  Two fish from the renal elimination 
studies were used to measure the GFR.  The means (±SD) determined for these 
animals were 5.40 (±1.33) mL/h/kg and 5.14 (±0.56) mL/h/kg.  Both values are close to 
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that given previously for chambered trout (6.1 mL/h/kg; McKim et al., 1999).  Based on 
this agreement and the fact that GFR determinations require a substantial amount of 
blood, we decided to forego these measurements on other fish used to characterize 
urinary elimination of PFOS. 
Models developed from renal and branchial elimination experiments 
Representative plasma and urine data from a renal elimination experiment are 
shown in Figure 3-2.  The log-transformed plasma concentration-time course 
demonstrates a clear distribution phase lasting approximately 24 h, followed by a log-
linear elimination phase.  From the slope of this log-linear phase, it is apparent that the 
terminal elimination half-life is much longer than the total study period.  The renal 
elimination data represent the cumulative amount (nanograms) of PFOS eliminated over 
time.  These data show that fish eliminated measurable quantities of PFOS to urine 
throughout the experiment.  Initially, data from the renal elimination experiments were 
simulated using a model that includes a fitted “other” elimination term, k4,1 (Supplemental 
Data, Appendix 2, Figures S3-1–S3-6).  Based on this evaluation, CLR was determined 
on average to account for only 1% of CLT, whereas the balance of clearance (99%) was 
attributed to branchial elimination (Supplemental Data, Appendix 2, Table S3-1).  
Importantly, the term (k3,1) which describes renal elimination of PFOS was informed by 
measured concentrations of PFOS in urine during the entire experimental time course.  
For this reason, our confidence in fitted values of k3,1 was relatively high.  In contrast, k4,1 
was largely determined by the kinetics of PFOS in plasma during the terminal elimination 
phase, which was typically represented by 4 data points.  Because of this lack of data at 
later time points as well as the observed low rate of PFOS elimination from plasma, our 
confidence in fitted values of k4,1 was relatively low.
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Figure 3-2.  Kinetics of perfluorooctane sulfonate (PFOS) elimination to urine following a bolus intra-arterial injection.  Data and 
model simulations are shown for Fish 1.  These simulations were generated by adopting the average branchial elimination rate 
constant from branchial elimination studies as an estimate of the elimination rate constant k4,1.  Measured concentrations in plasma 
are shown as solid dots.  Open triangles denote the cumulative mass of PFOS eliminated in urine.  Lines show the optimized fit of 
model simulations to measured values: solid line – plasma; dashed line – urine.  
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Table 3-1.  Physiological performance of chambered fisha 
 
Study design 
Parameter 
Bolus dose, renal 
elimination studies 
Bolus dose, branchial 
elimination studies 
Branchial uptake 
studies 
Weight (g) 1037 (285) 928 (131) 1147 (345) 
Ventilation volume (VVOL; L/d/kg) 304.1 (159.1) 318.9 (86.0) 295.6 (165.7) 
Oxygen consumption (VO2; (mg/d/kg) 1941 (815) 1125 (289) 1718 (732) 
Urine flow rate (UFR; L/d/kg) 0.073 (0.019) not measured not measured 
aReported values are given as the mean (SD) for each study design. 
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Table 3-2. Kinetic parameters and tissue–plasma concentration ratios for fish used in branchial elimination studies 
 Fish 7 Fish 8 Fish 9 Fish 10 Fish 11 Fish 12 Mean (SD) 
Gender ♀ ♀ ♂ ♀ ♂ ♀  
Weight (g) 1130 870 774 838 929 1025 928 (131) 
Kinetic parameters            
VC (mL/kg) 55.0 79.3 51.7 87.0 102.8 81.6 76.23 (19.56) 
k1,2 (1/d) 1.69 0.64 3.96 1.22 1.63 2.29 1.90 (1.15) 
k2,1 (1/d) 4.64 1.30 15.56 5.34 3.33 5.71 5.98 (4.96) 
k3,1 (1/d)  0.023 0.028 0.032 0.043 0.015 0.021 0.027 (0.010) 
k4,1 (1/d) 0.0069a 0.0069a 0.0069a 0.0069a 0.0069a 0.0069a 0.0069a 
VSS (mL/kg) 206 241 255 469 313 285 295 (93) 
CLB (mL/d/kg) 1.24 2.21 1.64 3.73 1.56 1.70 2.01 (0.90) 
CLR (mL/d/kg) 0.38b 0.55b 0.36b 0.60b 0.71b 0.57b 0.53 (0.14)b 
CLT (mL/d/kg) 1.62 2.76 2.00 4.33 2.27 2.26 2.54 (0.95) 
T1/2 (d) 88.0 60.6 88.2 75.0 95.3 87.1 82.3 (12.5) 
AICc 8.44 8.88 7.38 8.17 8.69 8.52 8.42 (0.38) 
BICd 8.59 9.03 7.96 8.31 8.84 8.67 8.57 (0.38) 
Tissue–plasma ratios at takedown         
 
Liver 0.38 0.59 0.84 0.39 0.32 0.38 0.48 (0.20) 
Kidney 0.23 0.38 0.31 0.30 0.17 0.16 0.26 (0.09) 
Muscle 0.039 0.024 0.031 0.020 0.012 0.014 0.023 (0.010) 
Bile 0.022 0.033 0.017 0.004 0.001 0.020 0.016 (0.012) 
aRenal elimination rate constant; set equal to average value determined in the “renal plus other” modeling exercise (Table S3-1).  See text for 
details. 
 bCalculated as the product of VC and a fixed value of k4,1.  The reported variance in the mean therefore reflects only the 1 
variance in VC.  2 
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cAkaike information criterion (AIC)  3 
dBayesian information criterion (BIC) 4 
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Table 3-3. Kinetic parameters and tissue–plasma concentration ratios for fish used in renal elimination studies 
 Fish 1 Fish 2 Fish 3 Fish 4 Fish 5 Fish 6 Mean (SD) 
Gender ♀ ♀ ♂ ♂ ♂ ♀  
Weight (g) 1346 814 1400 1033 934 694 1037 (285) 
Kinetic parameters             
VC (mL/kg) 29.4 49.8 122.0 77.4 45.5 41.6 60.9 (33.9) 
k1,2 (1/d) 4.53 3.21 14.66 1.38 3.44 8.23 5.91 (4.85) 
k2,1 (1/d) 17.60 13.36 33.52 5.23 14.19 21.37 17.54 (9.49) 
k3,1 (1/d) 0.0093 0.0064 0.0029 0.0043 0.0092 0.0082 0.0067 (0.0027) 
k4,1 (1/d) 0.027a 0.027a 0.027a 0.027a 0.027a 0.027a 0.027a 
VSS (mL/kg) 143 257 401 372 233 150 259 (109) 
CLB (mL/d/kg) 0.79b 1.38b 3.28b 2.08b 1.26b 1.15b 1.66 (0.90)b 
CLR (mL/d/kg) 0.27 0.32 0.35 0.33 0.42 0.34 0.34 (0.05) 
CLT (mL/d/kg) 1.06 1.70 3.63 2.41 1.68 1.49 1.99 (0.91) 
T1/2 (d) 93.8 105.0 76.7 106.9 96.3 69.5 91.3 (15.2) 
AICc 7.86 7.31 7.08 7.75 8.47 7.11 7.60 (0.54) 
BICd 8.01 7.46 7.23 7.90 8.62 7.25 7.75 (0.54) 
Tissue–plasma concentration ratios at takedown         
Liver 0.42 NSe 0.83 1.71 0.70 0.70 0.87 (0.49) 
Kidney 0.22 NSe 0.49 0.75 0.27 0.29 0.41 (0.2) 
Muscle 0.027 NSe 0.042 0.075 NSe NSe 0.048 (0.025) 
aBranchial elimination rate constant; set equal to the average value determined by modeling data from branchial elimination experiments (Table 
3-2).  See text for details. 
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bCalculated as the product of VC and a fixed value of k4,1.  The reported variance in the mean therefore reflects only the variance in VC.  
cAkaike information criterion (AIC)  
d Bayesian information criterion (BIC) 
eNS = Sample lost or not collected
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Data and model simulations from a representative branchial elimination 
experiment are shown in Figure 3-3.  Additional plots are provided elsewhere 
(Supplemental Data, Appendix 2, Figures S3-7–S3-11), and calculated parameters for 
all 6 fish are given in Table 3-2.  To simulate these data sets, we used the average CLR 
determined from the “renal plus other” modeling exercise as a fixed input.  The model 
was then used to fit the branchial elimination rate constant by simulating measured 
concentrations of PFOS in expired water.  The average CLB determined in this manner 
was 79% of CLT.  Thus, 79% of total PFOS clearance was attributed to elimination in 
expired water, whereas the balance (21%) was assumed to be the result of urinary 
elimination.  The mean VSS determined in this modeling effort was 295 mL/kg, whereas 
the average T1/2 was 82.3 d.  Finally, using the average branchial elimination rate 
constant from the branchial elimination studies as a fixed input, we remodeled data from 
the original set of renal elimination experiments.  Model simulations generated in this 
manner are shown in Figure 3-2.  Additional plots for the other renal elimination 
experiments are given elsewhere (Supplemental Data, Appendix 2, Figures S3-12–S3-
16).  For each animal, the quality of model fit was nearly identical to that obtained in the 
initial modeling effort (Table 3-3).  Moreover, fitted values of k3,1 were very close to those 
determined in the original modeling exercise.  In contrast, fitted values for VC and VSS 
were higher than those determined initially, whereas calculated CLT values were 
substantially lower.  It is clear, therefore, that although models developed in both efforts 
performed similarly (as judged by AIC and BIC values), optimized model fits were 
obtained differently.
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Figure 3-3.  Kinetics of perfluorooctane sulfonate (PFOS) elimination to expired branchial water following bolus intra-arterial 
injection.  Data and models simulations are shown for Fish 7.  Measured concentrations in plasma are shown as solid dots.  Open 
squares denote the cumulative mass of PFOS eliminated in expired water.  Lines show the optimized fit of model simulations to 
measured values: solid line = plasma; dashed line = water. 
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Because the second modeling effort was informed by measured PFOS 
concentrations in urine and expired water (albeit from separate experiments), our 
confidence in the second set of fitted parameters is much greater than that in the first set 
of fitted terms.  Further confidence in these models was gained by noting consistencies 
that exist between calculated parameters and parameters developed from the branchial 
elimination studies.  Thus, CLR was determined, on average, to account for 17% of CLT, 
whereas CLB accounted for the remainder (83%).  The average CLT (1.99 mL/d/kg) was 
close to that (2.54 mL/d/kg) determined in branchial elimination studies, as were the 
average VSS (259 mL/kg vs 295 mL/kg) and T1/2 (91.3 d vs 82.3 d).  
Figure 3-2 shows that fish 1 eliminated approximately 6 µg of PFOS to urine 
during the 72-h test period.  During the same time period, fish 7 (Figure 3-3) eliminated 
approximately 20 µg of PFOS to expired water.  These values correspond to 0.6% and 
2% of the administered dose, respectively.  Qualitatively similar results were obtained for 
the other test animals.  These findings indicate that >95% of the injected dose was 
retained by the fish at test termination, which is consistent with the long estimated T1/2 
values. 
These experiments were not designed to study sex differences in PFOS 
elimination by trout, and it is not possible to draw a statistically meaningful conclusion 
based on them.  It should be noted, however, that the average CLR values (mean ± SD) 
determined for each sex in the renal elimination studies were nearly identical (0.37 ± 
0.05 mL/d/kg and 0.31 ± 0.04 mL/d/kg for males and females, respectively; n = 3).  An 
examination of calculated CLT values from both the renal and branchial elimination 
studies also suggests that there were no trends with respect to gender. 
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Figure 3-4.  Kinetics of perfluorooctane sulfonate (PFOS) in trout plasma during a continuous waterborne exposure.  Data and model 
simulations are shown for Fish 13.  Measured values are shown as individual points.  The fitted model simulation is shown as a solid 
line. 
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Table 3-4.  Kinetic parameters and tissue–plasma concentration ratios for fish used in branchial uptake studies 
 Fish 13 Fish 14 Fish 15 Fish 16 Fish 17 Fish 18 Mean (SD) 
Gender ♀ ♀ ♀ ♀ ♀ ♂  
Weight (g) 1035 1102 998 1432 1237 1565 1147 (345) 
PFOS water exposure (ng/mL)a 3.25 3.25 3.25 1.84 1.84 3.31  
Kinetic parameters               
kU (L/d/kg) 0.87 0.94 0.39 0.58 1.27 1.07 0.85 (0.29) 
Uptake efficiency (%) 0.28 0.56 0.06 0.30 0.48 0.48 0.36 (0.18) 
Tissue–plasma ratios               
 Liver 1.39 0.62 2.10 0.64 1.90 1.06 1.28 (0.63) 
 Kidney 0.69 0.27 0.56 0.06 0.12 0.07 0.29 (0.27) 
 Muscle 0.042 0.017 0.064 BQb BQb BQb 0.041 (0.024) 
 Bile NSc 0.033 0.031 0.044 0.131 0.070 0.062 (0.042) 
aPFOS = perfluorooctane sulfonate 
bBQ = Concentration too low to quantify 
cNS = Sample lost or not collected
 89 
 
 
PFOS elimination to bile 
Although the methods employed in the present study did not permit a time-
dependent assessment of PFOS elimination to bile, bile produced by chambered trout 
tends to be retained within the gallbladder.  It is possible, therefore, to evaluate this route 
of elimination by measuring the volume of stored bile and resulting concentration of 
PFOS.  Bile was collected for all animals in the branchial elimination experiments.  The 
bile to plasma concentration ratios for these animals averaged 0.016, which suggests 
that PFOS was not actively secreted into bile.  The mean PFOS concentration in bile at 
the conclusion of the exposure was 56.5 ng/mL, and the average volume of collected 
bile was 3.1 mL.  Multiplying these values gives an average total mass of 175 ng, which 
is substantially lower than the average cumulative mass of chemical eliminated by the 
renal and branchial routes (4.1 µg and 22.1 µg, respectively).  It remains possible that 
biliary elimination of PFOS is more important in feeding animals because of higher bile 
flow rates.  However, the oral bioavailability of PFOS in trout is close to 100% (Martin et 
al., 2003a).  It is likely, therefore, that any PFOS eliminated to bile would be reabsorbed 
in the gastrointestinal tract.  Taken together, these observations suggest that bile 
represents a minor route for PFOS elimination in trout.  Branchial uptake experiments 
Branchial uptake rate constants (kU; L/d/kg) were obtained by fitting a 2-compartment 
model (Figure 3-1B) to measured plasma concentration time-course data from 
continuous waterborne exposures.  A representative plot is shown in Figure 3-4.  Plots 
for the other 5 animals are provided elsewhere (Supplemental Data, Appendix 2, Figures 
S3-17–S3-21).  Fitted rate constants were then used along with the measured VVOL for 
each animal to calculate a set of chemical uptake efficiencies (as kU/VVOL; Table 3-4).  
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Branchial uptake rate constants averaged 0.85 L/d/kg.  Calculated branchial uptake 
efficiencies were very low, averaging 0.36%.  
Tissue distribution experiment 
Data from the tissue distribution experiment were developed as a set of tissue to 
plasma concentration ratios to investigate how rapidly the fish approached an internal 
steady state (Table 3-5).  The lowest liver to plasma, muscle to plasma, and bile to 
plasma ratios were calculated for fish sampled on day 1.  However, these values did not 
differ statistically from ratios calculated at later time points (one-way analysis of 
variance, α = 0.05).  The rank order of measured PFOS concentrations in tissues on day 
3, day 7, and day 14 was plasma > liver > kidney >> muscle ≈ bile. 
The tissue distribution data were not sufficient to calculate a full chemical mass 
balance.  Nevertheless, it was possible to estimate the fraction of the administered dose 
in sampled tissues at different time points, assuming that each tissue comprises a fixed 
fraction of total body weight (Table 3-5).  A fractional body weight of 2.45% was used for 
plasma, assuming a fractional blood volume of 3.5% and hematocrit of 30% (Barron et 
al., 1987).  Fractional body weights for the other tissues were taken to be 67% for 
muscle, 1.27% for liver, and 0.76% for kidney (Nichols et al., 1990).  At first glance, 
these calculated values suggest that more than half of the administered dose was 
eliminated during the first 24 h post dosing.  However, this assessment does not account 
for PFOS contained in nonsampled tissues, which may have been substantial.  Based 
on the chambered studies, it is clear that PFOS injected into the bloodstream distributes 
to other tissues in <24 h, substantially reducing the measured concentration in plasma.  
From 24 h on, calculated mass-balance values from the tissue distribution experiment 
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changed little, if at all.  Thus, PFOS contained in these tissues after the distribution 
phase tended to remain within the animal. 
Plasma binding 
The recovery of PFOS from spiked samples of plasma ultrafiltrate averaged 66.5 
± 15.2%.  In contrast, PFOS concentrations in filtrates of whole plasma were below the 
limit of quantitation (5 ng/mL).  It was not possible, therefore, to estimate plasma binding 
with any certainty.  However, it appears that this binding exceeded 99%. 
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Table 3-5.  Perfluorooctane sulfonate (PFOS) tissue–plasma concentration ratios at 1, 3, 7 and 14 days post dosinga 
  Controls Day 1 Day 3 Day 7 Day 14 
Gender 1 ♂, 3♀ 2 ♂, 2♀ 2 ♂, 1♀ 4♀ 3 ♂, 1♀ 
Weight 333 (52) 308 (36) 268 (47) 245 (33) 288 (35) 
PFOS plasma conc.       BQb 8046 (413) 5983 (820) 6779 (794) 6737 (902) 
Tissue–plasma ratios  
    
Liver BQb 0.29 (0.06) 0.51 (0.21) 0.65 (0.33) 0.58 (0.34) 
Kidney BQb 0.25 (0.02) 0.25 (0.02) 0.22 (0.07) 0.21 (0.04) 
Muscle BQb 0.010 (0.001) 0.020 (0.004) 0.014 (0.005) 0.016 (0.002) 
Bile BQb 0.002 (0.001) 0.022 (0.013) 0.019 (0.002) 0.035 (0.026) 
Mass-balance estimates - % of initial dose remaining 
  
Plasma BQb 19.7 (1.0) 14.7 (2.0) 16.6 (1.9) 16.5 (2.2) 
Muscle BQb 5.3 (0.7) 7.8 (0.8) 6.1 (1.7) 7.0 (0.3) 
Liver BQb 3.0 (0.7) 3.8 (1.5) 5.4 (2.6) 4.8 (2.3) 
Kidney BQb 1.5 (0.0) 1.1 (0.1) 1.2 (0.3) 1.0 (0.1) 
aData presented as the mean (SD), n = 4 
bBQ = Concentration too low to quantify   
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Table 3-6.  Comparison of kinetic parameters for perfluorooctane sulfonate (PFOS) 
and perfluorooctanoic acid (PFOA) determined in chambered studies with rainbow 
trouta 
 
PFOS PFOAb 
Branchial uptake efficiency (%)c 0.36 (0.18) 0.10 (0.07) 
CLB (mL/d/kg) 1.83 (0.88)d 2.88 (1.20) 
CLR (mL/d/kg) 0.43 (0.14)d 32.40 (25.68) 
CLT (mL/d/kg) 2.26 (0.94)d 35.28 (26.64) 
VSS (mL/kg) 277 (98)d 524 (138) 
 T1/2 (d) 86.9 (14.1)d 12.6 (7.2) 
aReported values are given as the mean (SD) 
bKinetic parameters for PFOA were obtained from Consoer et al. (2014) 
cDetermined in branchial uptake studies 
dCalculated from values determined in both the renal and branchial elimination 
studies.   
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Discussion 
Although commercial production of PFOS has stopped, this compound continues 
to receive attention because of its persistence in the environment, large one-time 
production volumes, accumulation in biota, and demonstrated toxicity (Lau et al., 2007).  
Previous studies with fish have shown reproductive impairment in swordtails 
(Xiphophorus hellerii; Han, 2010) and developmental toxicity in both swordtail (Han and 
Fang, 2010) and zebrafish (Danio rerio; Shi et al., 2008; Huang et al., 2010) embryos.  
Additional work has provided evidence for hepatotoxicity in common carp (Cyprinus 
carpio; Hoff et al., 2003) and effects on zebrafish embryo behavior (Huang et al., 2010).  
To date, the only detailed study of PFOS kinetics in fish is that provided by Martin et al. 
(Martin et al., 2003a) which was performed as part of a larger effort to characterize the 
bioconcentration and tissue distribution of several PFAAs in rainbow trout.  The 
branchial uptake rate (kU) determined in this earlier effort was 53 L/d/kg, and the 
reported T1/2 was 15 d.  By comparison, the kU determined in the present study is 
approximately 50 times lower (0.85 L/d/kg) and calculated T1/2 values are 5 to 6 times 
longer (82.3 d and 91.3 d for the branchial and renal elimination experiments, 
respectively). 
When making these comparisons, it is important to consider that trout used in 
chambered experiments averaged more than 1 kg, whereas the fish used by Martin et al. 
(2003a) weighed approximately 7 g.  For example, the average measured ventilation 
rate (VVOL) of chambered fish used for branchial uptake studies was 295.6 L/d/kg.  The 
average VVOL of a 7-g trout is unknown.  However, using the allometric relationship 
developed previously by Consoer et al. (2014) (VVOL = 10.6 WB0.65, where VVOL is in 
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L/h/kg and WB is the fish’s weight in kilograms), we may estimate its value to be 
approximately 60.2 L/h/kg, or 1444.8 L/d/kg.  Based on this information, it is clear that 
some of the observed difference in fitted kU values from the present study and that 
performed by Martin et al. (2003a) can be attributed to likely differences in VVOL. 
Similar considerations apply to the interpretation of differences in T1/2.  Thus, 
higher ventilation rates (weight-normalized) in smaller fish can be expected to result in 
higher rates of PFOS elimination across the gills.  We are not aware of any allometric 
data on urine production in fish.  However, because the need to eliminate water can be 
expected to increase with increased rates of gill ventilation, it is reasonable to assume 
that urine production scales to a fractional exponent of body weight. 
Measured concentrations of PFOS from the tissue distribution experiment 
suggested that the injected chemical approaches an internal steady state in 1 d to 3 d.  
This finding is consistent with the short distributional phase evident in measured plasma 
time-course data from bolus injection experiments.  The rank order of PFOS 
concentration in tissues at 3 d, 7 d, and 14 d post dosing was plasma > liver > kidney >> 
bile ~ muscle.  Comparisons with the study performed by Martin et al. are complicated 
by the fact that these authors reported measured concentrations graphically as log-
scaled values (Martin et al., 2003a; see Figure 2).  However, an examination of these 
data suggests that the only difference between this and the present study relates to 
measured concentrations in liver and kidney.  Thus, Martin et al. (2003a) found that 
PFOS concentrations in these tissues were approximately equal, whereas in the present 
study measured concentrations in liver were 2 to 3 times greater than those in kidney.  
A major objective of the present study was to obtain data needed to compare the 
kinetics of PFOS and PFOA in rainbow trout.  Although structurally similar, these 
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compounds differ with respect to their acid terminal groups and the total number of 
fluorinated carbons (PFOS has 8, whereas PFOA has 7).  Perfluorooctane sulfonate has 
been shown to accumulate in trout, whereas PFOA does not (Martin et al., 2003a).  
These differences cannot be explained by differences in ionization state since 
dissociation constant values for both compounds are far lower than environmental pH 
values. 
In Table 3-6, modeled kinetic parameters from the present study are compared 
with those obtained in an earlier study with PFOA (Consoer et al., 2014).  Branchial 
uptake efficiencies for both PFOS and PFOA are <1%.  This finding is consistent with a 
substantial body of work showing that ionized compounds are poorly absorbed across 
fish gills (Saarikoski et al., 1986; Erickson et al., 2006; Nichols et al., 2015).  
Nevertheless, the mean branchial uptake efficiency for PFOS is 3.6 times higher than 
that for PFOA.  Taken alone, this difference would be expected to result in modestly 
greater accumulation of the sulfonate. 
The mean CLB for PFOA is approximately 50% greater than that for PFOS.  
However, to estimate rate constants for branchial elimination of each compound (kB; 
1/d), these clearance rates must be divided by modeled estimates of VSS (i.e., kB = 
CLB/VSS).  Although fitted VSS values for both compounds are substantially less than 1.0, 
the value determined for PFOA is somewhat larger than that for PFOS.  Taking this 
difference into account, the calculated kB for PFOS (0.0072/d) is slightly larger than that 
for PFOA (0.0055/d) and favors greater accumulation of the carboxylate. 
The most striking difference in kinetic parameters provided in Table 3-6 relates to 
modeled CLR values.  In earlier studies with PFOA, CLR averaged 89% of CLT, with CLB 
making up the remainder (Consoer et al., 2014).  In percentage terms, the results of the 
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present study indicate that for PFOS the relative importance of these processes is 
reversed.  Thus, the CLR for PFOS determined by averaging data from all 12 elimination 
experiments was 19% of CLT.  Expressed in absolute terms, differences in CLR for PFOS 
and PFOA (0.43 mL/d/kg vs 32.4 mL/d/kg) are even more apparent and suggest that the 
processes responsible for renal elimination of PFOA are approximately 75 times more 
efficient that those for PFOS.  Based on this information, it is clear that differences in T1/2 
for PFOS and PFOA can be largely attributed to differences in CLR. 
The mechanistic basis for this difference in renal handling of PFOS and PFOA 
remains to be determined.  In mammals, however, it is well known that species and 
gender differences in the plasma half-life of different PFAAs are strongly associated with 
differences in urinary elimination (Butenhoff et al., 2004; Andersen et al., 2006; Han et 
al., 2012).  For the PFCAs, these differences are particularly large, and a substantial 
amount of work has been performed to understand the basis for these observations.  
This research suggests that renal clearance within a particular species (or gender) 
reflects the net result of secretion to urine and reuptake from urine to plasma (Han et al., 
2012).  Both processes are mediated by membrane transporters localized to renal 
proximal tubule cells.  These proteins operate at both the basolateral and apical 
membranes and include several organic ion transporters (OATs/Oats; capital letters are 
used to denote human transporters) and organic anion transport polypeptides 
(OATPs/Oatps). 
Gene expression studies indicate that fish possess a diverse array of membrane 
transport proteins (Loncar et al., 2010; Popovic et al., 2010; Fischer et al., 2011; Verri et 
al., 2012; Luckenbach et al., 2014) many of which have been shown to transport 
xenobiotic compounds (Miller et al., 1998; Bard, 2000; Doi et al., 2001; Sturm et al., 
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2001; Sturm and Segner, 2005; Zaja et al., 2008; Zaja et al., 2011; Fischer et al., 2013; 
Uchea et al., 2015).  Functional characterization studies have been performed on 
several adenosine 5’-triphosphate binding cassette (ABC) transporters from fish.  By 
comparison, functional studies of solute carrier proteins (including Oats and Oatps) are 
more limited.  Organic ion transporters cloned from several fish species have been 
expressed in Xenopus laevis oocytes to study their substrate specificity (Wolff et al., 
1997; Aslamkhan et al., 2006; Meier et al., 2007).  All were shown to promote uptake of 
well-known substrates for mammalian OATs/Oats including p-aminohippuric acid, 
adenofir, 2,4-dichlorophenoxyacetic acid (2,4-D), estrone sulfate, phalloidin, and 
microcystin.  More recently, Popovic et al. (2014) evaluated interactions between 
zebrafish Oatp 1d1 and a number of environmental contaminants, including both PFOA 
and PFOS.  These studies showed that PFOA is a strong uncompetitive inhibitor of Oatp 
1d1 and PFOS is a high affinity substrate.  Winter flounder efficiently secreted 
chlorophenol red (an organic acid) and p-aminohippuric acid into urine (Mackenzie et al., 
1977).  Subsequent work showed that flounder eliminate 2,4-D by the same pathway 
(Pritchard and James, 1979).  Finally, several studies with aglomerular fish have shown 
that endogenous organic acids are eliminated to urine by mechanisms that do not 
involve glomerular filtration (Bayenbach, 2004). 
The results of the present study do not prove that differences in renal tubular 
transport of PFOS and PFOA are responsible for observed differences in urinary 
elimination of these compounds; nevertheless, they are highly suggestive.  Using the 
approach outlined by Consoer et al. (2014) we may compare the measured CLR for 
PFOS to that expected from measured rates of glomerular filtration and an estimated 
level of plasma binding.  For example, assuming a GFR of 5.5 mL/h/kg (based on the 
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present study as well as McKim et al. (1999) and plasma binding of 99% or 99.9%, the 
renal clearance predicted from simple glomerular filtration would be 1.3 mL/d/kg or 0.13 
mL/d/kg, respectively.  Given the uncertainty that exists in plasma binding estimates for 
PFOS, either prediction is indistinguishable from the CLR (0.43 mL/d/kg) determined in 
the present study for trout.  In contrast, the measured CLR for PFOA is much higher than 
that predicted from measured glomerular filtration and any plausible level of plasma 
binding. 
Research is needed to better understand the processes responsible for renal 
elimination of PFOS, PFOA, and other PFAAs by fish.  Of special interest is the 
possibility that PFCAs are actively secreted in the fish kidney, whereas PFSAs are not 
as this would provide a simple explanation for observed differences in the 
bioaccumulation of these chemical subclasses.  Alternatively, it is possible that both 
PFCAs and PFSAs are secreted to urine; however, different transporters may promote 
the reabsorption of PFOS and other PFSAs, prolonging their elimination half-lives.  
Thus, the underlying basis for differences in elimination of PFOA and PFOS by trout may 
be analogous to that responsible for observed species and gender differences in 
elimination of PFOA by mammals.  Finally, differences in renal handling of PFOS and 
PFOA by trout may be related to the total number of fluorinated carbons.  One way to 
address this possibility would be to measure the renal clearance of perfluorononanoic 
acid, which has the same number of fluorinated carbons as PFOS. 
Additional work is required to evaluate possible species-based and gender-based 
differences in renal handling of PFAAs, as well as the concentration dependence of 
these processes.  Lee and Schultz (2010) reported that female fathead minnows 
eliminate PFOA more rapidly than males.  This difference was partially reversed by 
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pretreatment of females with a synthetic androgen, suggesting that the mechanisms 
responsible for elimination of PFOA are controlled in part by sex hormones.  Similar 
findings reported in studies with rodents have been attributed to hormonal control of 
membrane transporter expression (Kudo et al., 2002).  In principal, renal clearance 
mediated by a specific transport protein would have the potential to saturate at high 
substrate concentrations.  This could, in turn, result in concentration-dependent changes 
in T1/2.  To address this possibility, De Silva et al. (2009) exposed trout to a high (81.1 
ng/g) and a low (6.9 ng/g) dietary dose of technical PFOA (78% n-isomer).  Half-life 
values determined from the depuration phase of these exposures did not vary with dose.  
The authors noted, however, that both dose levels may have saturated the pathways 
responsible for elimination. 
The present study, together with that of Consoer et al. (2014), clearly 
demonstrates the critical importance of renal clearance as a determinant of PFAA 
accumulation in fish.  Mechanistic models that explicitly consider this process, such as 
that given by Ng and Hungerbühler (2013) are therefore appropriate.  Both studies also 
provide detailed information on rates of chemical uptake and elimination across the gills, 
as well as elimination to bile, which may be used to further refine such models.  As such, 
these efforts substantially advance current understanding of this important class of 
environmental contaminants.  
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Chapter 4: Conclusion 
 Overview of kinetic studies with PFOA (Chapter 2)   
The goal of studies described by Consoer et al. (2014) was to better understand 
the processes which control uptake and elimination of PFOA in rainbow trout.  Initially, 
large trout confined to respirometer-metabolism chambers were given a bolus dose of 
PFOA to characterize the kinetics of elimination.  In these experiments, branchial and 
renal elimination were studied concurrently, allowing a direct comparison for each animal 
in the study, as well as in aggregate.  The resulting data sets were analyzed using a two-
compartment clearance-volume model with elimination from the central compartment, 
and parameter estimation was achieved by simultaneously fitting measured PFOA 
concentrations in plasma, urine, and expired water.  The results showed that trout 
eliminate approximately 90% of PFOA in urine (mean, all experiments), with a smaller, 
but still measurable fraction eliminated in expired water.  The mean terminal elimination 
half-life (T1/2) for PFOA was 12.6 d, while the mean steady-state volume of distribution 
(VSS) was 524 mL/kg.   
Branchial uptake of PFOA was studied in a separate set of experiments in which 
trout were exposed to a constant concentration of PFOA in water.  An attempt was made 
to directly measure PFOA uptake based on differences in concentration in inspired and 
expired water.  However, these concentration differences were too small to calculate a 
meaningful uptake rate.  Instead, branchial uptake was evaluated using a model-based 
analysis of plasma concentration time-course data.  For this analysis, model parameters 
that describe chemical elimination in urine and expired water were set equal to average 
values determined in bolus dosing studies.  Using this approach, the branchial uptake 
efficiency for PFOA was determined to be approximately 0.1%.  This low value is 
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consistent with earlier work on branchial uptake of ionized substances by fish (Armitage 
et al., 2017). 
The rank order of measured PFOA concentrations in tissues at the end of the 
uptake and elimination experiments was: plasma > liver ≈ kidney > muscle.  This pattern 
is similar to that reported in previous studies with trout (Martin et al., 2003).  Measurable 
quantities of PFOA were detected in bile; however, a simple mass-balance analysis 
indicated this was a minor route elimination.  A separate tissue distribution experiment 
was performed to evaluate changes in PFOA concentration over time.  The tissue 
concentration time-course data suggested that PFOA distributes rapidly within the 
animal, reaching an internal equilibrium in less than 24 h.  This finding is consistent with 
plasma time-course data from the bolus dosing studies, which demonstrated a relatively 
short distributional phase (< 12 h) followed by an extended log-linear elimination phase.         
Overview of kinetic studies with PFOS (Chapter 3) 
In a follow-up study (Consoer et al., 2016), trout confined to respirometer-
metabolism chambers were used to investigate uptake and elimination of PFOS.  The 
fish were again administered the chemical as a bolus dose, and the resulting data sets 
were evaluated using a two-compartment clearance-volume model.  Unlike earlier 
studies with PFOA, however, renal and branchial elimination were evaluated using two 
different sets of animals.  Initially, these data sets were used to independently fit rate 
constants for urinary and branchial elimination.  The results from both studies were then 
combined to develop a single coherent model description.    
Based on these investigations, it was determined that trout eliminate 
approximately 81% of PFOS across the gills (mean, all experiments), with renal 
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elimination accounting for most of the remainder.  A simple mass-balance calculation 
again showed that PFOS elimination in bile did not contribute substantially to overall 
clearance.  The mean T1/2 for PFOS was 86.9 d, while the mean fitted VSS was 277 
ml/kg. 
Additional studies were conducted to investigate the uptake of PFOS from 
respired water.  As with PFOA, uptake from water was characterized by modeling to 
measured chemical concentrations in plasma.  The mean branchial uptake efficiency 
determined in this manner was 0.36%.   
Measured concentrations of PFOS in tissues at the conclusion of the elimination 
studies exhibited the rank order: plasma > liver > kidney > muscle.  These findings were 
again consistent with distribution patterns reported by Martin et al. (2003).  The results of 
a separate time-course study indicated that the distribution of PFOS to tissues was 
rapid, although the liver/plasma concentration ratio appeared to increase somewhat 
between 24 and 72 h.  A mass-balance analysis of measured PFOS concentrations in 
tissues suggested that there was little loss of chemical from fish over the 14-day time-
course experiment.  This finding is consistent with the long estimated T1/2 for this 
compound.  
Comparison of the PFOA and PFOS studies 
 A detailed comparison of modeled kinetic parameters for PFOA and PFOS was 
provided in Chapter 3 of this dissertation.  A brief summary of this discussion is provided 
here.  Qualitatively, PFOS was found to be eliminated primarily across the gills, while 
PFOA was eliminated primarily in urine.  The mean total clearance rate (CLT) for PFOA 
was 35.3 mL/d/kg, while that determined for PFOS was 2.0 mL/d/kg.  This large 
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difference in CLT was associated with a similarly large difference in T1/2 (mean of 12.6 d 
for PFOA vs. 86.9 d for PFOS).  The mean VSS for PFOS (277 mL/kg) was 
approximately half of that determined for PFOA (524 mL/kg).  The basis for this 
difference in VSS is unknown.  However, the fact that fitted VSS values for both chemicals 
were substantially less than 1.0 is consistent with the general finding that chemical 
concentrations in plasma were higher than those in tissues. 
 Modeled branchial clearance rates (CLB) for PFOA and PFOS differed by less 
than a factor of 2 (mean of 2.88 ml/d/kg for PFOA vs. 1.88 ml/d/kg for PFOS).  In 
contrast, the renal clearance rate (CLR) for PFOA (mean of 32.40 ml/d/kg) was 
approximately 75 time faster than that for PFOS (mean of 0.43 ml/d/kg).  From these 
findings it may be concluded that differences in CLT between the two compounds are 
driven largely by differences in CLR.  Modeled branchial uptake efficiencies for PFOA 
(mean of 0.1%) were somewhat lower than those determined for PFOS (mean of 
0.36%).  Taken alone, these differences in branchial uptake would be expected to result 
in modestly greater accumulation of PFOS, compared to the carboxylate.  It is clear, 
however, differences in renal clearance provide the most likely explanation for observed 
differences in accumulation of PFOS and PFOA in fish. 
 Implications for bioaccumulation assessment of PFAAs in fish 
 The larger aim of this research was to better understand the kinetics of PFAAs in 
fish in order to inform bioaccumulation assessments, and to provide an improved basis 
for developing predictive computational models.  A variety of models have been used to 
predict chemical bioaccumulation in fish.  Most of these models rely heavily on the 
specification of physicochemical characteristics such as KOW and pKa, and reflect, 
explicitly or implicitly, two simplifying assumptions: 1) chemical accumulation largely 
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reflects the tendency of neutral chemicals to partition out of water and into tissue lipids, 
and 2) membrane transport is dominated by passive diffusion of the neutral chemical 
species.  As noted previously, the reliance of these models on factors such as KOW limits 
their ability to describe the accumulation of compounds that do not fit the assumptions 
on which they are based.  Further, differences in accumulation of PFAAs in mammals 
have been shown to be dependent on differences in renal elimination.  These 
differences in renal elimination are believed to be due, in turn, to differences in chemical 
affinity for various renal transport proteins, as well as differences in expression of renal 
transporters in different species and sexes.  Because renal elimination is a key 
determinant of PFAA accumulation, and as renal elimination is based on factors not 
easily predicted from simple physiochemical properties, the use of most current models 
to predict PFAA accumulation in fish is problematic. 
To date, three models have been developed to describe the accumulation of 
PFAAs in fish (Webster and Ellis, 2010; Armitage et al., 2013; Ng and Hungerbühler, 
2013).  However, the model given by Ng and Hungerbühler (2013) is the only description 
which explicitly considers factors that are likely to control the rate and extent of 
accumulation, including interactions with specific binding proteins (serum albumin, fatty 
acid binding proteins) and the activities of renal membrane transporters.  Because of the 
dearth of data for many of these interactions in fish, most of the parameters in the model 
were specified using data from studies in mammals.  While there was some information 
available on interactions of PFAAs with fish plasma proteins, there were no data on 
interactions with fatty acid binding proteins, or direct measurements of gill uptake, gill 
elimination, and renal elimination in fish. 
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In a recent publication, Armitage et al. (2017) used information provided by 
Consoer et al. (2014, 2016) to re-evaluate the model given by Ng and Hungerbühler 
(2013).  Branchial transport rates predicted by the model were substantially higher than 
those measured by Consoer et al. (2014, 2016).  The model was therefore modified to 
decrease predicted rates of gill flux, resulting in a better match to measured values for 
both PFOA and PFOS.  T1/2 values predicted by the adjusted model were somewhat 
lower than reported values (2.67 days predicted vs. 12.6 days measured for PFOA; 68.7 
days predicted vs. 86.9 days measured for PFOS).  However, the model was 
parameterized using a range of measured albumin interaction values in fish, and T1/2 
predictions generated across this range of binding values overlapped measured T1/2 
values for both PFOA and PFOS.  Of particular note, renal clearance rates for PFOA 
and PFOS given by Consoer et al. (2014, 2016) were fairly well predicted by both the 
original and updated Ng and Hungerbühler (2013) models.  Based on these findings, 
Armitage et al. (2017) concluded that the binding of PFAAs to specific proteins and their 
elimination by membrane transporters in the kidney may be “read across” from 
mammals to fish; that is, both processes are critical determinants of PFAA accumulation 
in mammals and fish.  As such, the studies performed by Consoer et al. (2014, 2016) 
provide a concrete example of the need for detailed, mechanistic data on uptake and 
elimination of PFAAs in fish. 
Study retrospective  
If I had an opportunity to perform this research over again, the only thing I would 
do differently is conduct the PFOS and PFOA elimination studies the same way; that is, 
by using animals prepared for simultaneous collection of urine and expired water.  There 
are advantages to using separate animals for renal and branchial elimination studies.  
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These include ease of animal preparation, which results in a greater percentage of 
successful surgeries, and a simpler data acquisition regimen (fewer samples per test 
and fewer sample types, processed using fewer sample-specific methods).  In hindsight, 
however, it turned out to be far more advantageous to collect renal and branchial 
elimination data from each animal.  By doing so, it was possible to perform direct 
comparisons for each animal, rather than relying on aggregate measured values for two 
groups of animals.  This approach introduced more complexity to the modeling effort, as 
the models were developed by simultaneously fitting data for three concentrations of 
PFOA at each time point: plasma, urine, and expired water.  In the end, however, this 
approach resulted in a more a robust analysis which was easier to describe. 
Future directions 
Additional mechanistic data on PFAA kinetics in fish is needed to understand 
processes that govern the bioaccumulation of these chemicals, and to aid in 
development of predictive computational models.  One of the most obvious needs is to 
conduct kinetic studies with a wider range of chemical structures.  These studies are 
necessary to determine how differences in gill uptake, gill elimination, and renal 
elimination noted for PFOS and PFOA, two PFAAs with comparable perfluocarbon chain 
lengths but different acidic moieties, fit into more generalized patterns with respect to 
PFAAs as a diverse chemical class.   
Another research need is to better characterize plasma binding of PFAAs in fish.  
The binding experiments described in this dissertation showed only that plasma binding 
of PFOA and PFOS was very high (> 99%).  This still leaves some room for differences 
in bound/free fractions in plasma to contribute to observed differences in renal 
clearance.  As noted by Consoer et al. (2014), however, the renal clearance of PFOA 
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was far greater than that predicted from simple filtration of unbound chemical.  Thus, 
while an improved understanding of PFAA binding in fish plasma is still needed, the data 
reported in this dissertation indicate that differences in glomerular filtration cannot 
explain observed differences in renal clearance of PFOA and PFOS in trout. 
Finally, and perhaps most importantly, there is a need for additional research on 
processes that control renal clearance of PFAAs by fish.  The studies described in this 
dissertation suggest that renal clearance is a major determinant of PFAA kinetics in fish, 
and that differences in renal clearance substantially determine the extent to which 
individual PFAAs accumulate over time.  The experiments performed with chambered 
trout were not designed to directly evaluate the role of membrane transporters in renal 
elimination of PFAAs.  However, the results of these studies, when coupled our current 
understanding of PFAA kinetics in mammals, suggest that these transporters play a 
critical role in fish, as they do in mammals.   
A variety of in vivo, ex vivo, and in vitro methods have been used to study 
processes related to renal transport of PFAAs in mammals and (to a lesser degree) fish.  
For example, toxicokinetic studies using known inhibitors of renal transporters have 
been performed to study the role of specific classes of renal transporters.  Additional 
studies using intact, castrated, and ovariectomized rats have been conducted to 
investigate the effects of sex hormones on transporter expression (Vanden Heuvel et al., 
1992; Kudo et al., 2002).  Previously, Lee and Schultz (2010) used hormone treatments 
to study differences in PFOA elimination by male and female fathead minnows.  
Additional studies employing sex hormones and/or specific transport inhibitors like 
probenecid could be conducted to investigate the role of specific transporter classes in 
fish, as well as sexually determined expression of this activity.  Other in vivo studies with 
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mammals have been performed using animals deficient in the expression of specific 
transporters (Katakura et al., 2007).  Similar genetic knockout models could be 
developed using, for example, zebrafish (Amacher, 2008) to study the role of specific 
transporters in fish.   
In vitro methods used to study PFAA transport in mammals also could be 
adapted to study fish membrane transporters.  For example, Nakagawa et al. (2008) 
used a culture of HEK293 (human embryonic kidney) cells transiently transfected to 
express a number of human and rat OAT/Oat proteins to probe the ability of PFOA to 
inhibit uptake of known substrates across a range of PFOA concentrations.  Using 
similar methods, Steiner et al (2014) screened a rainbow trout cDNA library for a 
hypothesized trout ortholog for human OATP1.  A novel Oatp1d1 protein was identified, 
cloned, and transfected into human HEK293 cells.  Additional work was then performed 
to demonstrate the ability of this protein to transport a number of endogenous and 
exogenous substrates.  Using these and other in vitro methods it may be possible to 
identify membrane transporters responsible for renal clearance of different PFAAs in 
fish, and determine how the expression of these transporters varies among species for 
which genetic sequence information is available.  
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Appendix 1 
 
Supplemental data for Chapter 2:Toxicokinetics of perfluorooctanoate (PFOA) in 
rainbow trout (Oncorhynchus mykiss) 
 
 
Fig. S2-1.  Adsorption of PFOA to polyethylene tubing (Intramedic PE50) used for 
chronic cannulation of rainbow trout.  Measured concentrations of PFOA in solutions 
(plasma or physiological saline) exiting the cannula are shown as individual points.  The 
pumping rate was 1 mL/min and the nominal concentration of PFOA spiked into plasma 
was 25 ng/mL.  Additional details pertaining to the experimental design are provided in 
the Section 2.7, Quality controls. 
  
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 10 20 30
%
 B
a
s
e
li
n
e
Interval (30s/250uL)
Cannula test  (PFOA)
Spiked plasma
Clean saline
 129 
 
 
Fig. S2-2.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 2.  In this and the following seven figures (S2-2 to S2-9), measured 
concentrations in plasma are shown as solid dots.  Open triangles and open squares 
denote the cumulative mass of PFOA eliminated in urine and expired water, 
respectively.  Lines show the optimized fit of model simulations to measured values: 
solid line – plasma; short dashes – expired water; long dashes – urine.  Sampling was 
terminated after 56 h due to failure of the exposure system.   
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 Fig. S2-3.   Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 3.    
 
Fig. S2-4.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 4. 
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Fig. S2-5.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 5. 
 
 
Fig. S2-6.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 6.  
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Fig. S2-7.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 7. 
 
 
Fig. S2-8.  Kinetics of PFOA elimination from trout following a bolus intra-arterial 
injection – Fish 8.  
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Fig. S2-9.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure – 
Fish 2.  Measured values in this and the follow six figures (S2-9 to S2-15) are shown as 
individual points.  The fitted model simulation is shown as a solid line. 
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Fig. S2-10.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 3.  
 
 
Fig. S2-11.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 4.  Sampling was terminated at 48 h due to unexplained death of the animal.  
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Fig. S2-12.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 5. 
   
 
Fig. S2-13.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 6.  
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Fig. S2-14.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 7. 
  
 
 Fig. S2-15.  Kinetics of PFOA in trout plasma during a continuous waterborne exposure 
– Fish 8.   
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Appendix 2 
 
Supplemental data for Chapter 3: Toxicokinetics of perfluorooctane sulfonate in rainbow trout (Oncorhynchus mykiss) 
Table S3-1. Kinetic parameters and tissue/plasma concentration ratios for fish used in renal elimination studies, determined using a “renal plus 
other” model 
 Fish 1 Fish 2 Fish 3 Fish 4 Fish 5 Fish 6 Mean (SD) 
Gender ♀ ♀ ♂ ♂ ♂ ♀  
Weight (g) 1346 814 1400 1033 934 694 1037 (285) 
Kinetic parameters             
VC (mL/kg) 29.9 46.3 54.6 74.5 45.6 36.8 47.9 (15.5) 
k12 (1/d) 0.2051 0.1720 0.3329 0.1151 0.1748 0.4246 0.237 (0.117) 
        
k21 (1/d) 0.6995 0.6348 1.4817 0.2671 0.6186 1.1402 0.807 (0.432) 
k31 (1/d) 0.00038 0.00028 0.00018 0.00013 0.00038 0.00038 0.00029 (0.00011) 
k41 (1/d) 0.0141 0.0216 0.0583 0.0259 0.0134 0.0145 0.025 (0.017) 
VSS (mL/kg) 132 217 297 247 207 135 206 (64) 
CLR (mL/d/kg) 0.27 0.31 0.24 0.24 0.42 0.33 0.30 (0.07) 
CLT (mL/d/kg) 10.36 24.37 76.60 46.51 15.12 13.11 31.01 (25.93) 
T1/2 (d) 48.0 31.6 11.8 26.6 50.1 46.6 35.8 (15.1) 
AICa 7.89 7.31 7.37 7.60 8.51 6.64 7.55 (0.63) 
BICb 8.06 7.49 7.54 7.77 8.68 6.81 7.73 (0.62) 
Tissue/plasma concentration ratios at takedown         
Liver 0.42 NSc 0.83 1.71 0.70 0.70 0.87 (0.49) 
Kidney 0.22 NSc 0.49 0.75 0.27 0.29 0.41 (0.2) 
Muscle 0.06 NSc 0.05 0.04 NSc NSc 0.05 (0.01) 
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aAkaike information criterion (AIC)  
bBayesian information criterion (BIC) 
cNS = Sample lost or not collected 
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Figure S3-1.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 1.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1.  In this and Figures S3-
2—S3-6 measured concentrations in plasma are shown as solid dots, while open 
triangles denote the cumulative mass of PFOS eliminated in urine.  Lines show the 
optimized fit of model simulations to measured values: solid line – plasma; dashed line – 
urine. 
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Figure S3-2.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 2.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1. 
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Figure S3-3.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 3.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1. 
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Figure S3-4.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 4.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1. 
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Figure S3-5.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 5.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1. 
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Figure S3-6.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 6.  Simulations were obtained 
using a model that includes a fitted “other” elimination term k4,1. 
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Figure S3-7.  Kinetics of PFOS elimination to expired branchial water following bolus 
intra-arterial injection.  Data and models simulations are shown for Fish 8.  In this and 
Figures S3-8—S3-11 measured concentrations in plasma are shown as solid dots, while 
open squares denote the cumulative mass of PFOS eliminated to expired water.  Lines 
show the optimized fit of model simulations to measured values: solid line – plasma; 
dashed line – water. 
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Figure S3-8.  Kinetics of PFOS elimination to expired branchial water following bolus 
intra-arterial injection.  Data and models simulations are shown for Fish 9. 
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Figure S3-9.  Kinetics of PFOS elimination to expired branchial water following bolus 
intra-arterial injection.  Data and models simulations are shown for Fish 10. 
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Figure S3-10.  Kinetics of PFOS elimination to expired branchial water following bolus 
intra-arterial injection.  Data and models simulations are shown for Fish 11. 
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Figure S3-11.  Kinetics of PFOS elimination to expired branchial water following bolus 
intra-arterial injection.  Data and models simulations are shown for Fish 12. 
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Figure S3-12.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 2.  Simulations were 
generated by adopting the average branchial elimination rate constant from branchial 
elimination studies as the elimination rate constant k4,1.  In this and Figures S13-S16 
measured concentrations in plasma are shown as solid dots, while open triangles denote 
the cumulative mass of PFOS eliminated in urine.  Lines show the optimized fit of model 
simulations to measured values: solid line – plasma; dashed line – urine. 
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Figure S3-13.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 3.  Simulations were 
generated by adopting the average branchial elimination rate constant from branchial 
elimination studies as the elimination rate constant k4,1. 
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Figure S3-14.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 4.  Simulations were 
generated by adopting the average branchial elimination rate constant from branchial 
elimination studies as the elimination rate constant k4,1. 
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Figure S3-15.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 5.  Simulations were 
generated by adopting the average branchial elimination rate constant from branchial 
elimination studies as the elimination rate constant k4,1. 
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Figure S3-16.  Kinetics of PFOS elimination to urine following a bolus intra-arterial 
injection.  Data and model simulations are shown for Fish 6.  Simulations were 
generated by adopting the average branchial elimination rate constant from branchial 
elimination studies as the elimination rate constant k4,1. 
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Figure S3-17.  Kinetics of PFOS in trout plasma during a continuous waterborne 
exposure.  Data and model simulations are shown for Fish 14.  In this and Figures S3-
18—S3-21 measured values are shown as individual points.  The fitted model simulation 
is shown as a solid line. 
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Figure S3-18.  Kinetics of PFOS in trout plasma during a continuous waterborne 
exposure.  Data and model simulations are shown for Fish 15.   
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Figure S3-19.  Kinetics of PFOS in trout plasma during a continuous waterborne 
exposure.  Data and model simulations are shown for Fish 16.   
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Figure S3-20.  Kinetics of PFOS in trout plasma during a continuous waterborne 
exposure.  Data and model simulations are shown for Fish 17.   
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Figure S3-21.  Kinetics of PFOS in trout plasma during a continuous waterborne 
exposure.  Data and model simulations are shown for Fish 18.   
  
 
 
 
 
 
 
 
